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 I N T R O D U C T I O N 
 The brain ascending serotonergic system plays a key 
role in a broad range of behaviors, and its dysfunction 
has been implicated in the pathogenesis of psychiatric 
disorders, most notably depression, anxiety disorders, 
and obsessive–compulsive disorder. In mammals, the 
dorsal raphe nucleus (DRN) contains about half of the 
brain’s serotonergic neurons, the axons of which inner-
vate most of the forebrain. Serotonergic neurons in the 
DRN display slow and regular action potential–fi ring 
activity proportional to the level of behavioral activation 
across the sleep–wake–arousal cycle ( Jacobs and Azmitia, 
1992 ). The serotonergic tone in projection areas 
is regulated by negative feedback of serotonin (5-HT) o 
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exerted locally through the activation of axonal 5-HT1B 
autoreceptors and indirectly through suppression of fi r-
ing activity by activation of somatodendritic 5-HT1A 
autoreceptors in raphe nuclei ( Sharp et al., 1989 ;  Riad 
et al., 2000 ;  Crespi, 2009 ). The 5-HT1A autoreceptor-
mediated suppression of serotonergic neuron fi ring 
that we refer to as autoinhibition is of particular interest 
because it can control the entire serotonergic system. 
The level of functional expression of 5-HT1A autore-
ceptors infl uences a range of 5-HT–dependent brain 
functions such as amygdala-mediated emotional re-
sponse ( Fisher et al., 2006 ;  Fakra et al., 2009 ), formation 
and display of social defeat ( Cooper et al., 2008 ), auto-
nomic regulation ( Audero et al., 2008 ;  Baccini et al., 
2012 ), depressive endophenotype and responsiveness 
to antidepressant drugs ( Richardson-Jones et al., 2010 ), 
and aggression ( Audero et al., 2013 ). Despite numer-
ous studies on 5-HT1A autoreceptors, the physiological 
mechanism of autoinhibition remains elusive ( Albert 
et al., 2011 ;  Altieri et al., 2013 ). Specifi cally, the subcel-
lular 5-HT pool from which basal 5-HT o originates, as 
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that autoinhibition is mediated by a different mechanism 
than stimulation-evoked 5-HT release. Here, by using an 
electrophysiological approach, we show that autoinhibi-
tion of serotonergic neurons in the DRN is caused by 
continuous, activity-independent nonexocytotic 5-HT re-
lease, originating primarily from surrounding neurites. 
 M A T E R I A L S  A N D  M E T H O D S 
 All animal manipulations were performed according to the Euro-
pean Community guidelines for animal care (DL 116/92, applica-
tion of the European Communities Council Directive 86/609/
EEC) and were approved by the Committee for Animal Care and 
Experimental Use of the University of Florence. Male Wistar rats 
were purchased from Harlan Italy. Tryptophan hydroxylase-2 
knockout (Tph2   /   ) mice ( Gutknecht et al., 2012 ) were obtained 
from K.P. Lesch (University of Würzburg, Würzburg, Germany). 
After weaning, animals were housed in groups of three to fi ve per 
cage and maintained under standard laboratory conditions (food 
and water ad libitum, 12 12-h light–dark cycle with lights on from 
08:00 to 20:00, ambient temperature at 22 ± 1°C, and relative hu-
midity of 40–50%). Animals (3–10 wk of age at the experimental 
day) were anesthetized with isofl uorane (ether in early experi-
ments) and decapitated. The brain was rapidly removed and 
dissected in ice-cold gassed (95% O 2 and 5% CO 2 ) artifi cial 
cerebrospinal fl uid (ACSF) composed of (mM): 124 NaCl, 2.75 
KCl, 1.25 NaH 2 PO 4 , 1.3 MgCl 2 , 2 CaCl 2 , 26 NaHCO 3 , and 11  d -glu-
cose. The brainstem was sliced coronally into 250–400-μm-thick 
slices with a vibratome (DSK T1000; Dosaka). After recovery for at 
least 2 h at room temperature, the slices were individually trans-
ferred to the recording chamber and superfused continuously 
with warmed ACSF at a rate of   2 ml min   1 . Slices were allowed 
to equilibrate for at least 30 min before the beginning of the 
recording. Drugs were bath-applied through either peristaltic 
pump– or a gravity-driven perfusion system, and a complete ex-
change of the recording chamber volume occurred in   1 min. 
Neurons within DRN were visualized by infrared differential in-
terference contrast (IR-DIC) video microscopy with a Newicon 
camera (C2400-07; Hamamatsu) mounted on an upright micro-
scope (Axioskop; Carl Zeiss). Recordings were made using an am-
plifi er (EPC-10; HEKA). Data were analyzed using Patchmaster 
2 (HEKA), Clampfi t 9.2 (Molecular Devices), and Prism 5 soft-
ware (GraphPad Software). Patch pipettes were prepared from 
thick-walled borosilicate glass on an electrode puller (P-97 Brown-
Flaming; Sutter Instrument). 
 Loose-seal cell-attached recordings 
 Action potential–fi ring activity of serotonergic neurons was re-
corded by loose-seal cell-attached recordings on 350–400-μm-
thick slices from 80–200-g rats, at a temperature of 34–36°C. To 
reproduce the noradrenergic drive that facilitates serotonergic 
neuron fi ring during wakefulness in slices ( Levine and Jacobs, 
1992 ), ACSF was supplemented with the   1 agonist phenyleph-
rine (10 μM) ( Vandermaelen and Aghajanian, 1983 ). In some 
experiments, glutamatergic and GABAergic synaptic transmission 
was inhibited by supplementing ACSF with the cocktail of block-
ers as in whole-cell recording. The pipette solution for cell-at-
tached recordings contained (mM): 125 NaCl, 10 HEPES, 2.75 
KCl, 2 CaCl 2 , and 1.3 MgCl 2 , pH 7.4 with NaOH. Loose-seal cell-
attached recordings (5–20-MΩ seal resistance; 3–6-MΩ pipette re-
sistance) were acquired continuously in voltage-clamp mode with 
pipette potential maintained at 0 mV. Signals were fi ltered at 
3 kHz and digitized at 10 kHz. The fi ring rate was reported using 
10-s bins. Recordings were aborted if fi ring frequency was sensi-
tive to changes in pipette holding potential or if shape of action 
well as the nature of its release, has remained unre-
solved ( Piñeyro and Blier, 1999 ;  Adell et al., 2002 ). For 
example, studies in which the 5-HT o level in the DRN 
was directly measured with microdialysis in vivo have 
produced contradictory results, suggesting both that 
basal 5-HT o originates from the cytoplasmic pool and 
does not depend on serotonergic neuron fi ring activity 
( Adell et al., 1993 ), and that 5-HT o originates from 
action potential–dependent exocytotic release ( Matos 
et al., 1996 ;  Portas et al., 1996 ;  Tao et al., 1997 ). In the 
median raphe, microdialysis studies indicated exocy-
totic 5-HT release, although tonic activation of 5-HT1A 
autoreceptors was not detected under basal conditions 
( Bosker et al., 1994 ,  1996 ;  Adell and Artigas, 1998 ). Fi-
nally, the mechanism by which selective 5-HT reuptake 
inhibitor (SSRI) treatment increases [5-HT] o in raphe 
nuclei has also remained unresolved ( Albert et al., 
2011 ) despite being of considerable interest, as it has 
been hypothesized that autoinhibition caused by the in-
crease in [5-HT] o delays the therapeutic effect of SSRIs 
( Artigas et al., 1996 ). 
 Axons and dendrites of serotonergic neurons are 
abundant in raphe nuclei, although with a low rate of 
varicosities and synaptic specializations ( Descarries et al., 
1982 ;  Park et al., 1982 ). In some species, serotonergic 
neuron dendrites form conspicuous structures ( Felten 
and Harrigan, 1980 ;  Park et al., 1982 ) or contain vesicles 
( Chazal and Ralston, 1987 ) expressing vesicular mono-
amine transporter 2 (VMAT2;  Colgan et al., 2012 ). Ac-
cordingly, electrochemical detection of 5-HT o has shown 
that evoked serotonergic transmission in the DRN has 
characteristics of paracrine rather than classic, hard-
wired synaptic transmission ( Bunin and Wightman, 1998 ; 
 Bunin et al., 1998 ). Early functional studies have sug-
gested that 5-HT release in raphe nuclei might occur by 
canonical, impulse-dependent axonal exocytosis as well 
as by somatodendritic exocytosis or dendrodendritic 
inhibition ( Hery et al., 1982 ;  Wang and Aghajanian, 
1982 ). Subsequently, serotonergic inhibitory postsynap-
tic potentials were recorded from serotonergic neurons 
( Yoshimura and Higashi, 1985 ;  Williams et al., 1988 ;  Pan 
et al., 1989 ), and it is now assumed that 5-HT release 
from axonal collaterals causes autoinhibition ( Albert 
et al., 2011 ;  Altieri et al., 2013 ). In addition, it was recently 
demonstrated that depolarization and glutamate recep-
tor activation produce somatodendritic 5-HT exocytosis 
( De Kock et al., 2006 ;  Kaushalya et al., 2008 ;  Colgan 
et al., 2009 ,  2012 ). These studies have shown multiple 
ways to induce 5-HT release in raphe nuclei, but their 
involvement in autoinhibition has remained undefi ned. 
On the other hand, electrophysiological studies in vivo 
( Fornal et al., 1996 ;  Hajós et al., 2001 ;  Haddjeri et al., 2004 ) 
and in brain slices ( Liu et al., 2005 ;  Mlinar et al., 2005 ; 
 Evans et al., 2008 ) have revealed that basal 5-HT o toni-
cally activates 5-HT1A autoreceptors in the DRN in the 
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10 μM SR-95531 (6-imino-3-(4-methoxyphenyl)-1(6 H )-pyridazineb-
utanoic acid hydrobromide), and 2 μM CGP-55845 (3- N [1-(S)-
(3,4-dichlorophenyl)ethyl]
amino-2-(S)-hydroxypropyl- P -benzyl-phosphinic acid hydrochlo-
ride). The pipette solution consisted of (mM): 120 K gluconate, 
15 KCl, 2 MgCl 2 , 10 HEPES, 0.1 EGTA, 10 Na 2 -phosphocreatine, 
4 MgATP, and 0.3 Na 3 -GTP, pH 7.35 with KOH. Pipettes had a 
resistance of 2–5 MΩ. After establishing whole-cell recording con-
fi guration, serotonergic neurons were identifi ed on the basis of 
electrophysiological properties displayed in current-clamp mode 
( Li et al., 2001 ): action potential half-height width of >1.5 ms; 
absence of fast afterhyperpolarization; absence of depolarizing 
sag in response to hyperpolarizing pulse (from   60/  65 to 
  110/  120 mV); and maximal sustained fi ring rate of <12 Hz 
(in response to long depolarizing current pulses). The identity of 
most of the recorded neurons was pharmacologically confi rmed 
as serotonergic during the normal course of the experiment as 
they, contrary to nonserotonergic neurons in the DRN, showed 
prominent 5-HT1A receptor-activated GIRK current. Alterna-
tively, at the end of the recording, the serotonergic identity 
of neurons was confi rmed by activation of GIRK conductance of 
>3 nS in response to bath application of 5-HT1A receptor agonists 
R-8-OH-DPAT (30 nM) or 5-CT (10–30 nM). In these experi-
ments, we used an extracellular solution containing 5.5 mM K + 
(the additional 2.75 mM by Na + substitution) to increase the driv-
ing force for inward K + current and to shift K + reversal potential 
to a more positive value, permitting reliable detection of inwardly 
rectifying K + currents. Under these conditions, serotonergic neu-
rons displayed a linear current–voltage relationship at membrane 
potentials negative to   85 mV, where essentially all the ionic cur-
rent (apart from the seal leak) was being carried through GIRK 
channels when activated by 5-HT1A autoreceptors. We used 
hyperpolarizing voltage ramps from the holding potential of 
  65 mV (to   125 mV, every 10 s; 100 mV s   1 ; 3-kHz cutoff frequency 
low-pass fi lter; 10-kHz sampling frequency) and measured the 
conductance from the slope of inward K + current in range from 
  110 to   90 mV (G   110/  90mV ). To monitor access resistance 
throughout the recording, hyperpolarizing pulses (10 mV; 100-ms 
duration; 16-kHz low-pass fi lter; 25-kHz sampling frequency; cell 
capacitance cancellation circuit switched off) were interlaced with 
ramps. This protocol permitted stable recording and reliable 
G   110/  90mV measurement for at least 40 min and in some cases for 
more than 1 h, with the exception of experiments in Ca 2+ -free extra-
cellular solution, in which ohmic leak started developing after 
20–30 min of stable recording. To calculate net 5-HT1A autoreceptor-
activated GIRK current (I 5-HT1A ) and conductance (G 5-HT1A ) present 
during a recording, the 5-HT1A autoreceptor-insensitive current 
was measured at the end of a recording after the application of 
20–50 nM of the selective 5-HT1A receptor antagonist Way-100635 
for 10–15 min and subtracted from the total current. 
 Estimation of [5-HT] o from 5-HT1A autoreceptor-activated 
GIRK conductance 
 5-HT1A autoreceptor-activated GIRK conductance can be used as 
a 5-HT o sensor. The detection range of the sensor is determined 
by concentration dependence for 5-HT activation of the 5-HT1A 
autoreceptor. Although calibration of the sensor with known con-
centrations of 5-HT is impractical in situ because of poor penetra-
tion of 5-HT into DRN slice preparations ( Williams et al., 1988 ; 
 Mlinar et al., 2005 ), the useful range of the sensor can be esti-
mated on the basis of 5-HT concentration–response for I 5-HT1A 
activation calculated by using acutely isolated serotonergic neu-
rons, a preparation uncompromised by 5-HT reuptake and me-
tabolism. Based on such a calculated EC 50 of 30 nM for 5-HT and 
unitary Hill’s slope ( Penington et al., 1993 ), 10–90% of the GIRK 
conductance activation would correspond to [5-HT] o of 3.3–270 nM, 
with near-linear proportionality for concentrations in the 
current changed. Because experiments in this study depended on 
endogenous 5-HT, recordings were done from neurons located at 
least 40 μm below the slice surface ( Mlinar et al., 2005 ). Most re-
corded neurons were located in the dorsal and ventromedial part 
of the DRN. Neurons were identifi ed according to electrophysio-
logical criteria ( Vandermaelen and Aghajanian, 1983 ;  Allers and 
Sharp, 2003 ). Neurons were presumed to be serotonergic when, 
during at least a 5-min-long control period at the beginning of the 
recording, they displayed a slow (<5 Hz) and steady (coeffi cient 
of variation of instantaneous frequency, <20%) fi ring rate; asym-
metric action current (ratio of upstroke to downstroke amplitude, 
>3.5) with a long peak-to-peak interval (>1.2 ms, proportional to 
action potential half-height width). Only neurons with a stable 
baseline fi ring rate were used. Neurons having a fi ring rate of 
<0.8 Hz in phenylephrine-supplemented ACSF were not used be-
cause they typically had unstable baseline activity and often ceased 
to discharge action potentials. 
 In experiments in which pharmacological treatments caused 
obvious reduction or cessation of the spiking activity toward the 
end of the recordings, slices were perfused with 20–100 nM of 
the selective 5-HT1A receptor antagonist, Way-100635 ( N -(2-(-4
(2-methoxyphenyl)-1-piperazinyl)ethyl)- N -(2-pyridinyl) cyclohex-
ane carboxamide) for 10–15 min to ensure that the observed 
effect was caused by a [5-HT] o increase. Experiments in which 
Way-100635 failed to recover the fi ring rate to at least 90% of the 
predrug level were discarded. In control experiments, done in 
the absence of pharmacological treatments, bath application of 
100 nM Way-100635 for 15 min did not change the fi ring rate 
(  6.7 ± 8.9%; mean ± SD;  n = 9). In some experiments, Way-
100635 was substituted with 150 μM of G protein–gated inwardly 
rectifying potassium (GIRK) channel blocker, Ba 2+ (BaCl 2 ) 
for 5–7 min. Alternatively, at the end of recordings in which the 
fi ring rate did not substantially change in response to the ex-
perimental protocol, response to 5-HT1A receptor agonists R(+)-
8-hydroxy-2-(di- n -propylamino)tetralin (R-8-OH-DPAT; 30 nM) 
or 5-carboxamidotryptamine maleate (5-CT; 10 nM) were tested, 
and neurons in which fi ring was not abolished ( n = 3) were 
deemed unhealthy or nonserotonergic and excluded from analy-
ses. In some loose-seal cell-attached recordings, drugs were focally 
applied using PicoSpritzer III (General Valve Operation). For 
focal application, drugs were dissolved in the pipette solution 
used for cell-attached recordings and fi lled into a small-bore tip 
pipette (R pip of ≈6.8–8.2 MΩ). The pipette was positioned under 
IR-DIC, and drugs were ejected from the pipette tip by long pulses 
using minimal pressure (4.5–9 kPa) suffi cient to produce small 
tissue displacement as visualized with the microscope. 
 Single-unit extracellular recordings 
 In early experiments, the fi ring rate was recorded by conventional 
single-unit extracellular method using a submerged-type cham-
ber in which the slice was superfused on both surfaces. Record-
ings were made with glass microelectrodes fi lled with 150 mM 
NaCl and a resistance of 12–15 MΩ. Single-unit potentials were 
passed through a high input impedance amplifi er (NL 102G; 
Digitimer) and fi lters (band-pass 50 Hz to 5 or 10 kHz). The re-
sulting signal was digitized via Digidata 1200 (Axon Instruments) 
to a PC controlled by Clampex 8 (Axon Instruments) in a gap-free 
acquisition mode. 
 Whole-cell voltage-clamp recordings of GIRK current 
 Whole-cell recordings were done at 28–30°C from 250–300-μM-
thick slices of 3–5-wk-old animals. To block synaptic transmission, 
in whole-cell experiments ACSF was supplemented with a cocktail 
of glutamate and GABA receptor blockers consisting of: 10 μM 
NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-
7-sulfonamide disodium salt), 20 μM DAPV ( d -(-)-2-amino-
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(a) in extracellular solution, [K + ] o was 2.75 mM instead of 5.5 mM, 
and NBQX was substituted with 20 μM DNQX (6,7-dinitroquinox-
aline-2,3-dione disodium salt); (b) in most of the experiments, 
the pipette solution contained no EGTA, and K-gluconate was 
substituted with KCH 3 SO 3 ; and (c) slice thickness was 300–350 μm. 
The whole-cell confi guration was obtained, and the identity 
of neurons as serotonergic or nonserotonergic was established in 
current-clamp mode. To examine postsynaptic serotonergic re-
sponses in the DRN nonserotonergic neurons, smaller neurons 
( Descarries et al., 1982 ) (capacitance of 10–30 pF) were targeted 
for the recording. Neurons were considered nonserotonergic 
when they had an action potential half-height width of 0.5–1.0 ms. 
Additional distinguishing characteristics of nonserotonergic 
neurons in whole-cell recordings were: fast afterhyperpolarization 
after action potentials (in most cases); depolarizing sag in re-
sponse to hyperpolarizing pulse (from   60/  65 to   110/
  120 mV for 1 s; in most cases 10–15 mV); maximal sustained fi ring 
rate of >20 Hz, in response to 3-s-long depolarizing current pulses; 
and the absence or sometimes small <1 nS of GIRK conductance 
activation in response to the application of 5-HT1A receptor ago-
nists (30 nM R-8-OH-DPAT or 10–30 nM 5-CT). In a few cases in 
which the identity of the recorded neurons appeared ambiguous 
at the beginning of the recording, the recording was interrupted. 
After cell-type identifi cation, neurons were kept at the resting 
membrane potential in voltage follower mode, or, more often, 
held at   60 mV in voltage-clamp mode. To evoke serotonergic 
postsynaptic responses, slices were stimulated by bipolar-stimulat-
ing electrodes using a constant voltage simulator (DS2 Isolated 
Stimulator, Digitimer). We typically used one concentric bipolar 
electrode (125-μm diameter; Platinum-Iridium; CBARC75; FHC 
Inc.) placed 50–300 μm (mostly 200–250 μm) from the recording 
neuron and one large twisted bipolar electrode (Ni-Cr–insulated 
wires; 70-μm OD; interpolar distance of 100–110 μm; homemade) 
placed at a different angle at the distance of 300–750 μm from the 
neuron. Stimulating electrodes were positioned away from the 
recording neuron dendrites. The second stimulation electrode 
was used if stimulation with the fi rst one failed to evoke serotoner-
gic postsynaptic response. A stimulation attempt was considered 
unsuccessful when: (a) stimuli of increasing intensity did not 
evoke postsynaptic responses bigger than 0.5 pA (or 0.5 mV in 
current-clamp mode) but, at the same intensity, evoked a direct 
(nonsynaptic) electrical response in the recording cell; or (b) 
stimulation reached tissue damage intensity level (40–50 V; 200–
500-μs duration). In addition, because a subpopulation of seroto-
nergic neurons in vivo fi res doublets and short bursts of action 
potentials ( Hajós et al., 1995 ), in some of experiments where 
single stimuli were ineffective, we additionally tried to evoke 
5-HT–mediated inhibitory postsynaptic currents (IPSC 5-HT ) with a 
train of fi ve stimuli (5–50 Hz), although this resulted in no detect-
able IPSC 5-HT in all attempts in serotonergic ( n = 26) and non-
serotonergic ( n = 8) neurons. When serotonergic postsynaptic 
responses were evoked, recording proceeded with neurons held 
at   60 mV, and stimuli (200-μs duration) with intensity set to 
evoke full response were delivered at an interstimulus interval of 
30 s. Higher stimulation frequencies were not used, as they pro-
duced decay of serotonergic synaptic responses. 
 HPLC determination of 5-HT content in brainstem slices 
 The 5-HT content in raphe nuclei–containing brainstem slices 
was determined as described previously ( Mlinar et al., 2005 ). To 
allow for differential anatomical origin, slices corresponding 
to three specifi c coronal sections from each animal were distrib-
uted into different experimental groups, which consisted of an 
equivalent number of slices from all three sections. The slices 
were sonicated in ice-cold 0.1 M HClO 4 . After centrifugation, the 
supernatant was neutralized with phosphate buffer and analyzed 
10–100-nM range. Because the basal [5-HT] o in vivo is 10 nM, 
as measured by voltammetry ( Crespi et al., 1988 ), and the basal 
[5-HT] o under conditions in this study was expectedly slightly 
lower, both basal and elevated [5-HT] o should be within the 
range of the 5-HT1A–GIRK sensor. Furthermore, based on the 
EC 50 of 30 nM for 5-HT, the [5-HT] o can be estimated from G 5-HT1A 
if the zero value of G 5-HT1A is determined in response to the ap-
plication of Way-100635, and the maximal G 5-HT1A is calculated as 
the difference in G   110/  90mV recorded in the presence of a maxi-
mally active concentration of a 5-HT1A receptor full agonist (e.g., 
100 nM R-8-OH-DPAT or 30 nM 5-CT) and G   110/  90mV recorded 
in the presence of Way-100635. To precisely estimate the [5-HT] o , 
the maximal and zero G 5-HT1A should be determined for each re-
corded neuron. Because in this study it was important to obtain a 
reliable zero G 5-HT1A value, Way-100635 was applied at the end of 
all recordings, but maximal G   110/  90mV was determined only in a 
few experiments. For example, in the recording shown in  Fig. 8 
(A and B) , calculated G 5-HT1A was 2.33 nS in citalopram, 7.47 nS in 
citalopram plus  l -tryptophan (Trp), and 11.32 nS in 30 nM 5-CT, 
corresponding to [5-HT] o of 7.8 and 58 nM in citalopram and 
citalopram plus Trp, respectively. For the rest of the experiments, 
we can only approximate [5-HT] o by using the mean maximal 
G 5-HT1A value of 6.22 nS (SD of 2.27 nS; range of 3.31 to 11.32 nS; 
 n = 22), determined in response to the application of 30 nM 5-CT 
in experiments done under the same conditions (5.5 mM [K + ] o ). 
Based on the standard concentration–response curve, with the 
maximal G 5-HT1A value of 6.22 nS and unitary Hill’s slope, the 
change of 1 nS corresponds to the change of   31 nM in [5-HT] o 
for recorded G 5-HT1A within the range from   1.1 to 5.1 nS. 
 Rationale for the choice of 5-HT concentrations intracellularly 
applied through the recording pipette 
 To examine 5-HT effl ux from an individual serotonergic neuron, 
5-HT was included in the pipette solution. The concentration of 
5-HT in the cytosol of serotonergic neurons is in dynamic equilib-
rium, set by multiple variables, i.e., precursor availability, rates of 
synthesis and degradation, release, reuptake, and packaging into 
vesicles. Because the exact concentration of 5-HT normally present 
in the cytosol of mammalian serotonergic neurons is unknown, we 
used 5-HT at concentrations of 0.3 and 3 mM, assumed to be one 
to two orders of magnitude higher than normal, based on the fol-
lowing reasoning: (a) The upper limit of cytosolic 5-HT concentra-
tion in serotonergic neuron cell bodies is likely determined by 
monoamine oxidase type B (MAOB), which has a K m of   1.2 mM 
for 5-HT ( Fowler and Tipton, 1982 ). In our conditions, block of 
MAOB by deprenyl caused only a weak reduction in the fi ring rate 
(  14%; 1–10 μM; 60 min;  n = 10; not depicted), suggesting that 
cytosolic 5-HT is in a low micromolar range, well below MAOB K m 
value. (b) Considering an extracellular concentration of 10 nM 
5-HT in raphe ( Crespi et al., 1988 ), vesicular 5-HT concentration of 
  270 to ≥400 mM ( Bruns et al., 2000 ;  Balaji et al., 2005 ) and con-
centration gradients reachable by SERT ( Adams and DeFelice, 
2002 ) and VMAT2 ( Schuldiner et al., 1995 ) of ≥10 3 and >10 4 , re-
spectively, cytosolic 5-HT can be assumed to be   10–40 μM. (c) An 
intracellular 5-HT concentration of   50–380 μM was measured in 
large invertebrate serotonergic cells ( Fuller et al., 1998 ;  Hatcher 
et al., 2008 ). The cytosolic 5-HT concentration is expectedly lower 
because these measures include vesicular 5-HT, and it was esti-
mated that   26 and   17% of total 5-HT somatic content is pack-
aged into secretory vesicles in rat serotonergic neurons ( Colgan 
et al., 2009 ) and in differentiated RN46A cells ( Balaji et al., 2005 ), 
respectively. We thus assume that 300 μM 5-HT is at the upper limit 
of physiologically attainable cytosolic 5-HT concentration. 
 Whole-cell recording of serotonergic postsynaptic responses 
 Serotonergic synaptic responses were recorded in the same con-
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concentration, were aliquoted and stored at   20°C until use. Tbz 
was provided by R. Testa (Recordati S.p.A, Milan, Italy). Isofl urane 
was obtained from Baxter; tetrodotoxin (TTX) was from Alomone 
Labs; R-8-OH-DPAT, DAPV, SR-95531, and CGP-55845 were ob-
tained from Tocris Bioscience; DNQX was from Abcam; concana-
mycin A, HEPES, ATP, and DMSO were from Fluka; and all other 
substances were obtained from Sigma-Aldrich. 
 R E S U L T S 
 Relative paucity of functional serotonergic synaptic 
transmission in the DRN 
 It is well recognized that, in vivo and in raphe slice prep-
arations, the blocking of SERT-mediated 5-HT reuptake 
increases [5-HT] o and via activation of 5-HT1A autorecep-
tors suppresses serotonergic neuron fi ring. This indi-
cates that there is a continuous effl ux of 5-HT from 
with a computer-controlled HPLC system (ESA 5006; ESA) 
equipped with a refrigerated autosampler and an electrochem-
ical detector. 
 Statistical analysis 
 Statistical analysis was performed using Prism 5 (GraphPad Soft-
ware). For data groups with  n < 8, nonparametric tests were used. 
For data groups with  n ≥ 8, parametric tests were used if distribu-
tion was normal (P > 0.05) when tested with D’Agostino and Pearson 
omnibus normality test. Otherwise, appropriate nonparametric tests 
were used. Data are reported as mean ± SD, except for illustration 
of average time courses, where SEM is shown for clarity. 
 Drugs 
 Most of the drugs were prepared as stock solutions in distilled 
water. Tetrabenazine (Tbz) was prepared by dissolving Tbz free 
base in equimolar HCl. Concanamycin A (Folymicin) was prepared 
as a 10-mM stock solution in DMSO (0.05% fi nal). All stock solutions, 
which were at least a thousand times the highest experimental 
 Figure 1. Relatively inconspicuous evoked IPSC 5-HT in 
the DRN serotonergic neurons. (A) Electrical stimula-
tion–evoked serotonergic postsynaptic current in a seroto-
nergic cell is inhibited by the 5-HT1A receptor antagonist 
Way-100635 (50 nM). Superimposed traces are averages of 
11 and 7 individual traces recorded 0–5 min before (Ctrl) and 
after 7–10 min of Way-100635 application. Bars, 0.5 s, 6 pA. 
The recording electrode voltage command and the timing 
of the stimulus are shown above the traces. The voltage step 
(10 mV) preceding the stimulus was used to monitor the 
input resistance (R IN ). The stimulus artifact is truncated. 
(B) Histogram summarizing percent of successfully evoked 
IPSC 5-HT in the DRN serotonergic neurons with respect to 
the slice rostrocaudal level. Numbers of attempts are indi-
cated above the bars. Plate numbers correspond to those 
of the rat brain atlas ( Paxinos and Watson, 1998 ). (C) His-
togram showing percent of successfully evoked IPSC 5-HT 
in the centrocaudal part of the DRN compared with the 
recorded neuron location and stimulation electrode posi-
tion. Numbers of attempts are indicated above the bars. 
DRD, dorsal raphe dorsal subnucleus; DRV, dorsal raphe 
ventral subnucleus; VLPAG, ventrolateral periaqueductal 
gray; DRVL, dorsal raphe ventrolateral subnucleus; C/VC, 
caudal/ventrocaudal in longitudinal slice preparation. 
(D) Scatter plot of the maximal IPSC 5-HT amplitudes in a 
subset of experiments in which IPSC 5-HT were evoked by 
using the most effective arrangement, i.e., with both the 
recording neuron and the stimulating electrode located in 
the dorsal raphe ventral subnucleus (shown in E). Com-
parison of responses obtained in control conditions (Ctrl; 
mean of 8.0 pA; median of 8.9 pA;  n = 19; normal distribu-
tion; P = 0.57; D’Agostino and Pearson omnibus test) and 
in the presence of 5-HT precursor Trp (10 μM; mean of 
10.0 pA; median of 6.9 pA;  n = 24; nonnormal distribution; 
P < 0.0001; D’Agostino and Pearson omnibus test) revealed 
no signifi cant differences between groups, indicating that 
the observed, relatively small maximal amplitude IPSC 5-HT 
in the DRN are not caused by the reduced level of 5-HT 
in brain slice preparation. Symbols represent single experi-
ments. Bars represent median with interquartile range. 
(E) Photograph illustrating the most effective electrode place-
ment for evoking IPSC 5-HT in the DRN serotonergic neu-
rons. In 300-μm-thick slices containing the centrocaudal 
part of the DRN (corresponding to plates 51–53), this arrangement resulted in an   90% success rate and the highest amplitudes of suc-
cessfully evoked responses (shown in D). Two stimulating electrodes, one twisted and one concentric (right side), are positioned in the 
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and just outside of its dorsolateral margin. In slices con-
taining centrocaudal extent of the DRN, the probability 
of evoking an IPSC 5-HT in respect to different anatomi-
cal locations of stimulating electrodes and the recorded 
serotonergic neuron varied between   8 and   78% 
( Fig. 1 C ). The highest success rate was obtained with 
both the recording neuron and the stimulated elec-
trodes located either in the dorsal or in the ventral dor-
sal raphe subnucleus. A similar success rate (  70%) was 
previously observed by  Pan et al. (1989) in slightly dif-
ferent conditions. Evoked IPSC 5-HT in serotonergic 
neurons displayed rather small maximal amplitude. 
Post-hoc analysis of maximal IPSC 5-HT amplitudes of all 
successful attempts in the centrocaudal extent of the 
DRN showed median maximal amplitude of 6.90 pA 
with interquartile range from 3.35 to 11.75 pA ( n = 84; 
mean = 8.61 pA; nonnormal distribution; P < 0.0001; 
D’Agostino and Pearson omnibus test). To test for a 
possibility that such small responses are caused by a re-
duced level of 5-HT in the brain slice preparation, we 
compared maximal IPSC 5-HT amplitudes in the ventral 
subnucleus, in which the most prominent responses 
were observed, in control conditions and in the pres-
ence of the 5-HT natural precursor Trp. As shown in 
 Fig. 1 D , no signifi cant differences were observed in the 
presence of 10 μM Trp compared with the control, sug-
gesting that small maximal IPSC 5-HT amplitude is not 
caused by reduced 5-HT level in brain slices. Consistent 
with previous structural ( Descarries et al., 1982 ) and 
serotonergic neurons into the surrounding extracellular 
space. Because serotonergic neurons display pacemaker 
activity during wakefulness, it is reasonable to assume 
that 5-HT o is supplied by synaptic 5-HT release. By using 
whole-cell recordings in raphe neurons and electrical 
stimulation of nearby areas, we tested for the presence 
of IPSC 5-HT . In the presence of a cocktail of GABAergic 
and glutamatergic receptor blockers (DNQX, DAPV, 
SR-95531, CGP-55845, and strychnine; see Materials 
and methods), the electrical stimulation evoked slow 
inhibitory synaptic responses in serotonergic neurons. 
IPSC 5-HT were nearly abolished by the selective 5-HT1A 
receptor antagonist Way-100635 (50 nM; 7–8 min; 95.6 ± 
6.5%; mean ± SD;  n = 6; e.g.,  Fig. 1 A ), as expected for 
serotonergic synaptic responses in raphe. However, 
IPSC 5-HT in the DRN were not observed in all record-
ings. Stimulation attempts often failed to evoke IPSC 5-
HT , even with maximally attainable stimulation intensity 
(see Materials and methods). In total, in recordings 
from serotonergic neurons, IPSC 5-HT were observed in 
88 out of 191 stimulation attempts, whereas in nonsero-
tonergic neurons, small IPSC 5-HT (<5 pA) were observed 
only in 2 out of 59 cases (not depicted). A post-hoc as-
sessment of probability of evoking an IPSC 5-HT in seroto-
nergic neurons revealed higher success rates in slices 
containing centrocaudal extent of the DRN compared 
with its rostral extent ( Fig. 1 B ). As there are no clearly 
delineated fi ber tracts in the DRN, we tried to evoke 
IPSC 5-HT by stimulating different locations in the DRN 
 Figure 2. Inhibition of IPSC 5-HT by the VMAT2 inhibi-
tor Tbz. (A) Traces show evoked IPSC 5-HT before and 
after 20-min application of 10 μM Tbz. Superimposed 
traces are averages of 21 and 11 individual traces. Bars, 
1 s, 3 pA. (B) Average time course of evoked IPSC 5-HT 
inhibition by 10 μM Tbz ( n = 6; closed circles) and sham 
( n = 5; open circles). (C) Histogram summarizing the 
effect (mean ± SD) of 20-min-long Tbz (10 μM;  n = 6) 
and sham ( n = 5) application on evoked IPSC 5-HT ampli-
tude. Values for individual experiments were obtained 
using an average of fi ve traces after 20–22 min of appli-
cation versus average of 21 traces during the last 10 min 
in control. **, P = 0.0022; one-tailed Mann–Whitney 
test. (D and E) The effect of Tbz in the presence of 
10 μM Trp with continuous and interrupted stimulation. 
(D) Time course of the effect of 10 μM Tbz in an experi-
ment in which IPSC 5-HT were evoked in a single seroto-
nergic neuron by stimulating two separate inputs, one 
of which with constant stimulation (top) and the other 
with stimulation interrupted for the last 5 min before 
and the fi rst 20 min of Tbz application (bottom). 
(E) Superimposed average traces of evoked IPSC 5-HT 
before and after 20 min of application of Tbz of the re-
cording shown in D. Bars, 0.5 s, 3 pA (top); 0.5 s, 10 pA 
(bottom). (F) Histogram summarizing the decrease in 
evoked IPSC 5-HT amplitude (mean ± SD) after 20-min-
long Tbz application in the presence of 10 μM Trp with 
continuous ( n = 5) and interrupted ( n = 6) stimulation. 
Values for individual experiments were obtained using 
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5-HT level was restored by supplementing bath solution 
with 10 μM Trp. To test whether Tbz-induced loss of 
vesicular 5-HT is facilitated by vesicle turnover caused 
by the stimulation, in a subset of experiments stimula-
tion was interrupted during Tbz application. As shown 
in  Fig. 2 (D–F) , 20-min-long application of 10 μM Tbz 
decreased IPSC 5-HT by 79.3 ± 9.4% (mean ± SD;  n = 5) in 
the presence of continuous stimulation and by 69.9 ± 
20.8% (mean ± SD;  n = 6) in the absence of electrical 
stimulation. Although there was no signifi cant differ-
ences between groups, a trend toward weaker Tbz 
effectiveness in conditions of interrupted stimulation 
suggests that stimulation-induced vesicle turnover may 
in some extent facilitate the effect of Tbz. Longer Tbz 
application in the presence of 10 μM Trp produced 
near-complete inhibition of IPSC 5-HT (e.g., 28–30 min, 
continuous stimulation; 97.3 ± 2.5%; mean ± SD;  n = 4; 
not depicted), confi rming the validity of Tbz as a tool to 
assess the role of vesicular 5-HT pool. 
functional ( Pan et al., 1989 ) evidence, these fi ndings indi-
cate relative paucity of functional serotonergic synaptic 
transmission in the DRN. 
 Inhibition of IPSC 5-HT by Tbz 
 In an attempt to fi nd a pharmacological tool that can be 
used to assess the role of vesicular 5-HT release in the 
regulation of 5-HT o , we wanted to verify that the deple-
tion of vesicular 5-HT by the VMAT2 inhibitor Tbz re-
sults in IPSC 5-HT inhibition. As shown in  Fig. 2 , bath 
perfusion of a Tbz (10 μM for 20 min), in the presence 
of a cocktail of GABAergic and glutamatergic receptor 
blockers, decreased IPSC 5-HT by 93.4 ± 6.9% (mean ± SD; 
 n = 6;  Fig. 2, A–C ), without changing the recording 
neuron R IN (  1.1%; SD 4.4%; P = 0.56; Wilcoxon 
matched pairs test) and I Hold (  1.5 pA; SD 6.0 pA; P = 
0.84; Wilcoxon matched pairs test). We also examined 
dependence of the Tbz effect on 5-HT availability and 
the stimulation in a set of experiments in which slice 
 Figure 3. The characteristics of fi ring rate suppression by 
Trp. (A) Average time course of the effect of 30 μM Trp and 
subsequent addition of AADC inhibitor 1 μM NSD-1015 on 
DRN serotonergic neuron fi ring showing that suppression 
of fi ring by Trp depends on its conversion to 5-HT. Sym-
bols represent the mean ± SEM of the normalized, binned 
fi ring rate. (B) The correlation between Trp effect (30 μM; 
12–15 min) on serotonergic neuron fi ring rate expressed 
as absolute difference (top) or percent difference (bot-
tom) and the baseline fi ring rate. Symbols represent single 
experiments ( n = 77). Lines are best fi ts with correspond-
ing 95% confi dence intervals. r 2 and p-values refer to the 
linear least-square fi t. (C) Histogram of the decrease in fi r-
ing rate produced by 30 μM Trp in dorsal raphe subnuclei 
(mean, SD;  n = 46, 21, and 3). DRD, dorsal; DRV, ventral; 
DRI, interfascicular subnucleus. (D) Histogram of the de-
crease in fi ring rate produced by 30 μM Trp compared with 
the neuron location along the rostrocaudal axis (mean, 
SD;  n = 13, 19, 22, 18, and 5). Plate numbers correspond 
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varies in respect to the recorded neuron anatomical 
location. We found that the Trp application suppressed 
fi ring activity similarly in the DRN subnuclei ( Fig. 3 C ) 
and along the rostro-caudal extent of the DRN ( Fig. 3 D ). 
No analysis was done in respect to the lateral axis, nor 
was the ventrolateral subnucleus studied, as recordings 
were made from neurons located mostly within 150 μm 
from the midline. Thus, the magnitude of fi ring sup-
pression induced by bath application of 30 μM Trp 
exhibited a high variability but was rather uniform 
throughout the DRN. 
 Autoinhibition is independent of GABAergic and 
glutamatergic neurotransmission 
 The experiments on electrically evoked 5-HT release 
were performed in the presence of a cocktail of synaptic 
blockers and thus do not rule out the potential role of 
GABA and glutamate as cotransmitters or an indirect 
effect of the released 5-HT by modulation of neighboring 
GABAergic neurons and glutamatergic and GABAergic 
axon terminals. We therefore wanted to test whether au-
toinhibition depends on GABAergic and glutamatergic 
neurotransmission. Because local GABAergic neurons 
were implicated in the regulation of serotonergic neu-
ron activity ( Liu et al., 2000 ;  Tao and Auerbach, 2003 ) 
and under basal conditions for fi ring rate recording, 
i.e., in “Trp-free” phenylephrine-supplemented ACSF, 
some GABAergic neurons are electrically active, we fi rst 
examined whether they infl uence serotonergic neuron 
fi ring in slices. Under these conditions, in which autoin-
hibition was essentially absent, a separate or combined 
15-min-long bath application of 10 μM GABAA receptor 
antagonist bicuculline and 3 μM GABAB receptor 
antagonist CGP-55845 did not signifi cantly change the 
fi ring rate of serotonergic neurons, indicating a lack of 
GABAergic tone on serotonergic neurons (not depicted; 
bicuculline:   0.089 ± 0.181 Hz; mean ± SD;  n = 4; P = 
0.63; two-tailed Wilcoxon matched pairs test; CGP-55845: 
  0.023 ± 0.102 Hz; mean ± SD;  n = 6; P = 0.84; two-tailed 
Wilcoxon matched pairs test; coapplication:   0.12 ± 0.18 
Hz; mean ± SD;  n = 8; normal distribution; P = 0.51; 
D’Agostino and Pearson omnibus test; P = 0.09; two-
tailed paired  t test; single unit recordings). 
 We next tested whether GABAergic neurotransmis-
sion infl uences autoinhibition in slices in which 5-HT 
availability was restored approximately to the physiolog-
ical level by supplementing its precursor, Trp.  Fig. 4 
shows the effect of coapplication of GABAA receptor 
antagonist SR-95531 (10 μM) and GABAB antagonist 
CGP-55845 (3 μM) on the fi ring rate of serotonergic 
neurons, obtained by a single-unit recording in the 
presence of 10 μM phenylephrine and 30 μM Trp. A 
comparison of action potential fi ring rates recorded 
during the last minute in the antagonist mixture and 
during the last predrug minute revealed no signifi cant 
change in the fi ring rate (  0.10 ± 0.14 Hz; mean ± SD; 
 Characterization of fi ring suppression by Trp challenge 
in the DRN 
 We wanted to investigate the origin of 5-HT o respon-
sible for suppression of serotonergic neuron fi ring 
under physiologically relevant conditions. We previ-
ously showed that supplementing the bath solution with 
the 5-HT precursor Trp rescues endogenous 5-HT lev-
els in slices and suppresses action potential fi ring activ-
ity via activation of 5-HT1A autoreceptors ( Mlinar et al., 
2005 ) and that, in mice, this effect of Trp is fully depen-
dent on 5-HT1A autoreceptors and neuronal Tph2, as 
it is absent in slices obtained from Htr1a   /   ( Audero 
et al., 2013 ) and Tph2   /   mice ( Gutknecht et al., 2012 ). 
As shown in  Fig. 3 A , suppression of serotonergic neu-
ron fi ring by 30 μM Trp was completely reversed upon 
the addition of aromatic  l –amino acid decarboxylase 
(AADC) inhibitor NSD-1015 (3-hydroxybenzylhydrazine 
dihydrochloride), confirming that Trp conversion 
to 5-HT is required for fi ring suppression also in rat 
DRN ( Gallager and Aghajanian, 1976 ;  Evans et al., 
2008 ). In control experiments, bath application of 1 μM 
NSD-1015 (15 min), which did not change the fi ring 
rate by itself (  0.5 ± 4.2%; mean ± SD;  n = 11), pre-
vented suppression of fi ring by subsequently added Trp 
(30 μM; mean =   0.7%; range from 4.0 to   3.1%;  n = 3). 
In addition, fi ring suppression by the intermediate 
5-HT precursor, 5-hydroxytryptophan (5HTP; 30 μM) 
was also completely reversed by 1 μM NSD-1015 (98.7 ± 
3.1%; mean ± SD;  n = 5), whereas, 30 μM 5HTP 
(15 min), when applied in the presence of 1 μM NSD-1015, 
did not change serotonergic neuron fi ring rate (0.1 ± 
7.0%; mean ± SD;  n = 7). Thus, experiments on raphe 
slices using a Trp challenge are a practical model for 
studying autoinhibition in in vivo–like 5-HT–synthesiz-
ing conditions. In raphe slices, the Trp challenge sup-
pressed fi ring only partially, consistent with in vivo 
fi ndings ( Fornal et al., 1996 ;  Hajós et al., 2001 ;  Haddjeri 
et al., 2004 ). A post-hoc analysis of fi ring suppression by 
bath application of 30 μM Trp ( n = 77; pooled from all 
experimental groups in this study) revealed that the 
absolute difference in fi ring rate before and after Trp 
application (  0.386 ± 0.222 Hz; mean ± SD; normal 
distribution; P = 0.68; D’Agostino and Pearson omnibus 
test) is not signifi cantly correlated to the serotonergic 
neuron basal fi ring rate ( Fig. 3 B ; Spearman r s =   0.104; 
P = 0.37), whereas when the effect of Trp is expressed as 
percent difference (  25.9 ± 17.5%; mean ± SD; non-
normal distribution; P = 0.02; D’Agostino and Pearson 
omnibus test), there is a moderate correlation with the 
fi ring rate ( Fig. 3 B ; Spearman r s =   0.458; P < 0.0001). 
Therefore, to eliminate the infl uence of the basal fi ring 
rate on the magnitude of the Trp effect, we considered 
the absolute difference in fi ring rate as the relevant pa-
rameter instead of the more commonly used fractional 
difference. In addition, post-hoc analysis was done to 
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(  0.048 ± 0.080 Hz; mean ± SD;  n = 8; P = 0.141; two-
tailed Wilcoxon matched pairs test; nonnormal distri-
bution; P = 0.005; D’Agostino and Pearson omnibus 
test). These experiments showed that GABAergic and 
glutamatergic transmission do not contribute signi-
fi cantly to serotonergic neuron autoinhibition when 
in vivo–like 5-HT–synthesizing conditions were restored 
by Trp supplementation. 
 Autoinhibition is mediated by nonvesicular 5-HT release 
 Because both cytoplasmic and vesicular release of 5-HT 
have been implicated in the regulation of 5-HT o , we in-
vestigated their respective involvement in serotonergic 
neuron autoinhibition. The role of vesicular 5-HT pool 
was assayed with the VMAT2 inhibitor Tbz. When tested 
under basal conditions characterized by virtually absent 
autoinhibition, i.e., in phenylephrine-supplemented 
 n = 10; P = 0.055, two-tailed paired  t test; normal dis-
tribution; P = 0.19; D’Agostino and Pearson omni-
bus test). 
 We proceeded to test the possibility that glutamater-
gic neurotransmission contributes to autoinhibition, as 
glutamate receptor–dependent 5-HT release from sero-
tonergic cell bodies and dendrites has been demon-
strated previously ( De Kock et al., 2006 ;  Colgan et al., 
2012 ).  Fig. 4 C shows the effect of coapplication of the 
AMPA receptor antagonist NBQX (10 μM) and the 
NMDA receptor antagonist DAPV (20 μM) on the fi ring 
rate of serotonergic neurons, obtained by a loose-seal 
cell-attached recording in the presence of 10 μM phen-
ylephrine and 30 μM Trp. A comparison of action po-
tential fi ring rates recorded during the last minute in 
the antagonist mixture and during the last predrug 
minute revealed no signifi cant change in the fi ring rate 
 Figure 4. Autoinhibition is independent of GABAergic 
and glutamatergic transmission. Suppression of the seroto-
nergic neuron fi ring rate by Trp is not infl uenced by GABA 
and glutamate receptor block in single-unit (A and B) and 
loose-seal cell-attached (C) recordings in phenylephrine-
supplemented ACSF. (A) Time course of a representative 
experiment with coapplication of GABAA (SR-95531; 10 μM) 
and GABAB (CGP-55845; 3 μM) receptor antagonists. 
At the end of the recording, Trp-induced suppression of 
fi ring was reversed by the application of GIRK channel 
blocker Ba 2+ (BaCl 2 ; 150 μM). (B) Summary time course 
of experiments showing that coapplication of 10 μM SR-
95531 and 3 μM CGP-55845 did not change the fi ring rate 
in the presence of 10 μM phenylephrine and 30 μM Trp. 
Symbols represent the mean of the normalized, binned fi r-
ing rate, expressed as absolute difference in the baseline 
fi ring rate computed over the 5-min preceding Trp ap-
plication in each experiment. (C) Summary time course 
of experiments showing lack of effect of coapplication of 
AMPA and NMDA receptor antagonists on the fi ring rate. 
Symbols represent the mean of the normalized, binned 
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5-HT levels, which then resulted in an increased [5-HT] o 
( Fig. 5 D ). 
 We next wanted to test whether depletion of vesicular 
5-HT reverses Trp-induced autoinhibition, an effect 
that would occur if serotonergic neuron fi ring is under 
autoinhibitory control by exocytotic 5-HT release. For 
this, we examined the effect of 10 μM Tbz (15 min) on 
the fi ring rate in the presence of 10 μM phenylephrine 
and 30 μM Trp ( Fig. 6, A and B ). A comparison of fi ring 
rates during the last 3 min before Tbz (1.446 ± 0.367 Hz; 
mean ± SD;  n = 15; normal distribution; P = 0.06; 
D’Agostino and Pearson omnibus test) and during the 
last 3 min of Tbz application (1.300 ± 0.537 Hz; mean 
± SD;  n = 15; normal distribution; P = 0.15; D’Agostino 
and Pearson omnibus test) revealed no signifi cant 
change in fi ring rate, although a reducing trend was ob-
served (  0.146 ± 0.282 Hz;  n = 15; P = 0.058; two-tailed 
Wilcoxon matched pairs test; nonnormal distribution; 
P = 0.0046; D’Agostino and Pearson omnibus test). We 
also confi rmed that 30 μM Trp suppressed fi ring when 
ACSF, the application of 10 μM Tbz slightly but signifi -
cantly reduced DRN serotonergic neuron fi ring rate 
( Fig. 5, A and B ) and partially depleted 5-HT content in 
slices from the predrug level of 1.93 ± 0.84 pmol mg   1 
to 1.21 ± 0.44 pmol mg   1 in 10 min, and to 1.02 ± 
0.45 pmol mg   1 in 25 min, respectively (mean ± SD;  n = 9; 
 Fig. 5 C ). The effect of Tbz on fi ring was reversible upon 
the addition of the 5-HT1A receptor antagonist Way-
100635 (50–100 nM;  n = 5; not depicted; e.g.,  Fig. 5 A ) 
or GIRK channel blocker Ba 2+ (BaCl 2 ; 150 μM;  n = 6; not 
depicted). These effects of Tbz are consistent with its 
vesicle-depleting action, which occurred over the same 
time interval as the decrease in IPSC 5-HT (20–25 min; 
 Fig. 2 ) and as reported previously for a voltammetry-
detected decrease in the electrical stimulation–evoked 
5-HT release ( Bunin et al., 1998 ). The small reduction 
in neuron fi ring rate by Tbz in spite of the decrease in 
overall slice 5-HT content is likely attributable to leak-
age of vesicular 5-HT to cytosol and the consequent 
shift in equilibrium between cytosolic and extracellular 
 Figure 5. Effects of VMAT2 inhibitor Tbz in raphe 
slices. (A) Time course of a representative experi-
ment in phenylephrine-supplemented ACSF, show-
ing the decrease in fi ring rate produced by 10 μM 
Tbz. The neuron was confi rmed serotonergic, as its 
fi ring was abolished in response to bath perfusion of 
the 5-HT1A receptor agonist 5-CT (10 nM). The ap-
plication of 50 nM Way-100635 (Way) restored the 
fi ring rate to the level preceding Tbz, indicating that 
the effect of Tbz was mediated by 5-HT1A auto-
receptors. (B) Histogram summarizing the effect of 
10 μM Tbz on fi ring in phenylephrine-supplemented 
ACSF. Firing rates recorded at 9–10 and 22–25 min 
of the Tbz application were compared with the fi r-
ing rate recorded during the last 5 min in control. 
Repeated measures one-way ANOVA revealed a sig-
nifi cant decrease in the fi ring rate by Tbz ( n = 19; P < 
0.0001; normal distribution; P = 0.23, 0.08, and 0.09; 
D’Agostino and Pearson omnibus test). After 10 min 
of Tbz application, the fi ring rate was decreased by 
0.092 ± 0.136 Hz (mean ± SD; *, P < 0.05; Dunnett’s 
post-hoc test vs. the baseline), whereas at 25 min, the 
fi ring rate was decreased by 0.182 ± 0.194 Hz (mean 
± SD; ***, P < 0.001; Dunnett’s post-hoc test vs. the 
baseline). (C) Histogram summarizing the effect of 
10 μM Tbz on 5-HT content (pmol mg   1 wet tissue) 
in raphe slices. Columns represent average values 
for nine slices obtained from nine animals. Error 
bars denote SD. The left column represents control slices, perfused for 30 min in the experimental chamber with ACSF containing 
3 μM phenylephrine at 34°C. The middle and right columns represent slices that were additionally perfused with ACSF containing 
3 μM phenylephrine and 10 μM Tbz for 10 and 25 min, respectively. The groups were signifi cantly different (P = 0.0096; two-tail one-way 
ANOVA; normal distribution; P = 0.05, 0.29, and 0.97; D’Agostino and Pearson omnibus test; *, P < 0.05; **, P < 0.01; Dunnett’s post-hoc 
test vs. control). (D) Schematic diagram illustrating the expected redistribution of 5-HT after Tbz application. Concentration gradients 
of 5-HT across vesicular (>10 4 -fold;  Schuldiner et al., 1995 ) and plasma membrane (≥10 3 -fold;  Adams and DeFelice, 2002 ) are gener-
ated and maintained by VMAT2 and SERT, respectively. Block of VMAT by Tbz slowly dissipates the 5-HT gradient across the vesicular 
membrane, resulting in a decrease in vesicular 5-HT concentration and an increase in cytosolic 5-HT concentration, which in turn leads 
to an increase in [5-HT] o via reequilibration of plasma membrane 5-HT gradient. Dashed arrows indicate fl ux of 5-HT down the gradi-
ent and open arrows indicate direction of changes in 5-HT concentration within each compartment. Degradation of excessive cytosolic 
5-HT by MAOB (K m of ≈1.2 mM;  Fowler and Tipton, 1982 ) limits the increase in 5-HT concentration, resulting only in a weak reduction 
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± SD;  n = 9; normal distribution; P = 0.96; D’Agostino 
and Pearson omnibus test) revealed no signifi cantly 
change in the fi ring rate by concanamycin A (0.009 ± 
0.087 Hz;  n = 9; P = 0.76; two-tailed paired  t test). Col-
lectively, these experiments indicated that autoinhibi-
tion of the DRN serotonergic neuron fi ring is mediated 
by nonvesicular 5-HT release. 
 Autoinhibition is not mediated by SERT reverse transport 
 The physiological function of SERT is the reuptake of 
5-HT o , but SERT can operate in reverse direction, which 
applied 30–45 min after Tbz ( Fig. 6, C and D ). Finally, 
we asked whether these experiments with Tbz could be 
reproduced with a chemically unrelated substance that 
depletes secretory vesicles through a different mecha-
nism. For this purpose, we used the specifi c inhibitor of 
vacuolar-type H + -ATPase (V-ATPase), concanamycin A 
( Fig. 6, E and F ). A comparison of fi ring rates during 
the last 3 min before concanamycin A (1.456 ± 0.561 
Hz; mean ± SD;  n = 9; normal distribution; P = 0.90; 
D’Agostino and Pearson omnibus test) and during the 
last 3 min of the application (1.465 ± 0.572 Hz; mean 
 Figure 6. Autoinhibition is not mediated by vesicular release of 5-HT. (A) Time course of a representative recording showing that sup-
pression of the fi ring rate by 30 μM Trp was not affected by subsequent addition of 10 μM Tbz, whereas it was reversed by the addition 
of 150 μM BaCl 2 (Ba 2+ ). (B) Average time course of the effect of 30 μM Trp and subsequent addition of 10 μM Tbz on DRN serotonergic 
neuron fi ring. Symbols represent the mean ± SEM of the normalized, binned fi ring rate. (C) Time course of a representative recording 
illustrating suppression of the fi ring rate by 30 μM Trp in the presence of 10 μM Tbz. The effect of Trp was reversed by the addition of 
Way-100635. (D) Histogram summarizing the effect of 30 μM Trp in the presence of Tbz and the cocktail of glutamatergic and GABAer-
gic blockers. After 15 min of Trp application, the fi ring rate was decreased by 0.295 ± 0.177 Hz (mean ± SD;  n = 8; **, P = 0.0011; one-
tailed paired  t test; normal distribution; P = 0.41; D’Agostino and Pearson omnibus test). (E) Time course of a representative recording 
showing that suppression of the fi ring rate by 30 μM Trp was not affected by subsequent addition of the V-ATPase inhibitor concana-
mycin A (ConA; 5 μM), whereas it was reversed by the addition of 100 nM Way-100635. (F) Average time course of the effect of 30 μM 
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weaker maximal effect was observed (fi t bottom = 
26.7%; 9.7–43.6%; 95% C.I.; not different from Crtl, P = 
0.10, F = 2.71, extra sum-of-squares F test). Importantly, 
at the highest concentrations of citalopram applied, 
1–3 μM, expected to completely inhibit SERT, fi ring 
was maximally suppressed, indicating that SERT rever-
sal does not contribute to the release. On the other 
hand, an apparently weaker potency of citalopram in 
the presence of Tbz defi es easy explanation. It could be 
a consequence of redistribution of endogenous 5-HT 
after VMAT2 inhibition, in particular to the additional 
decrease in 5-HT content (see  Fig. 5, C and D ), as well 
as a direct consequence of decreased vesicular 5-HT re-
lease. To distinguish between these possibilities, the ef-
fect of SERT inhibition on fi ring was also studied in a 
higher number of neurons, under conditions of differ-
ent levels of cytosolic and vesicular 5-HT. We compared 
the effects of partial inhibition of SERT by 30 nM citalo-
pram (25 min) in baseline conditions (Trp-free ACSF), 
and in the continuous presence of Tbz or Trp, as well 
as coapplied Tbz and Trp ( Fig. 7 C ). To obtain match-
ing precitalopram fi ring rates among experimental 
groups, Trp was used at 10 μM, the concentration that 
results in a net effl ux of cytosolic 5-HT. Having estab-
lished that 5-HT release underlying autoinhibition is 
nonvesicular and hence from the cytoplasmic pool, we 
wanted to test the possibility that reverse transport of 
5-HT via SERT contributes to autoinhibition. The effect 
of SERT inhibition on the fi ring rate was studied by the 
application of citalopram, an SSRI that blocks SERT 
without inducing 5-HT effl ux ( Sitte et al., 2000 ). As 
shown in  Fig. 7 (A and B) , the dose–response relation-
ship of citalopram showed properties consistent with 
the single effect of inhibiting 5-HT reuptake. Under 
basal conditions (“Trp-free” ACSF), inhibition of SERT 
by citalopram decreased the fi ring rate with an EC 50 
of 73.7 nM (41.3–131.7 nM; 95% confi dence interval 
[C.I.]) and caused a near-complete suppression of fi r-
ing (fi t bottom = 2.1%;   18.8 to 23.0%; 95% C.I.), re-
vealing substantial continuous effl ux of 5-HT, even in 
slices having reduced 5-HT content (  60%;  Mlinar 
et al., 2005 ). Under conditions where vesicular 5-HT ac-
cumulation was inhibited by Tbz, citalopram was simi-
larly effective (EC 50 = 94.5 nM; 46.0–194.3 nM; 95% C.I.; 
log IC 50 not different from Ctrl, P = 0.58, F = 0.32, extra 
sum-of-squares F test), although a clear trend toward 
 Figure 7. 5-HT release is not mediated by SERT 
reversal. (A) A representative recording show-
ing the response of a DRN serotonergic neuron 
to increasing citalopram concentrations in the 
continuous presence of 10 μM Tbz. Ba, 150 μM 
BaCl 2 . (B) Comparison of concentration–re-
sponse relationships for citalopram obtained in 
the presence of 10 μM Tbz and in control condi-
tions. Individual points correspond to arithmetic 
means of fi ring rate normalized to the baseline 
fi ring rate; error bars represent SD. Solid lines 
are the best least-squares fi t to the logistic equa-
tion, b + (1   b)/(1 + (EC 50 /[Citalopram]) n H ), 
where  EC 50 is the half-maximally effective con-
centration,  n H is the Hill coeffi cient, and  b is the 
fraction remaining at the maximal citalopram 
effect (R 2 = 0.72, control; 0.47 in Tbz). (C) His-
togram summarizing change in action potential 
firing rate by partial inhibition of SERT by 
30 nM citalopram (25th min vs. last 5 min before 
citalopram) in control (Ctrl,  n = 24), Tbz (10 μM 
for 20 min;  n = 14), Trp (10 μM for 30 min; 
 n = 12), and Tbz plus Trp (10 μM each for 30 min; 
 n = 8). Error bars represent SD. The fi ring was 
signifi cantly reduced by 30 nM citalopram in all 
conditions (P < 0.0001, Ctrl; P = 0.0006, Tbz; 
P = 0.0005, Trp; P = 0.008, Tbz + Trp; Wilcoxon 
matched pair test). The effect of citalopram 
was significantly different among the groups 
(P = 0.0002, Kruskal–Wallis test; Ctrl: nonnormal 
distribution, P = 0.001; Tbz: normal distribu-
tion, P = 0.70; Trp: normal distribution, P = 0.27; 
Tbz + Trp: nonnormal distribution, P = 0.008; 
D’Agostino and Pearson omnibus test). Dunn’s 
post-hoc test revealed statistically signifi cant dif-
ferences for the citalopram effect between the 
Tbz and control groups (P < 0.05), between the 
Tbz and Trp groups (P < 0.001), and between 
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increase in inwardly rectifying K + conductance that was 
reversed by the addition of 50 nM Way-100635 ( Fig. 8, 
C–E ; representative of three experiments), indicating 
the persistence of 5-HT effl ux in the absence of fi ring. 
A similar increase in GIRK conductance by 1 μM citalo-
pram ( n = 3) was also obtained in conditions where 
both vesicular accumulation of 5-HT and action poten-
tial fi ring activity were prevented by bath application of 
10 μM Tbz (in bath solution for at least 25 min before 
the start of the experiment) and TTX. As shown in 
 Fig. 8 (F and G) , the addition of 30 μM Trp in the pres-
ence of TTX, Tbz, and citalopram produced an increase 
in GIRK conductance (mean 2.5 nS; range of 2.2 to 
2.7 nS;  n = 3; corresponding to an estimated increase in 
[5-HT] o of ≈80 nM; see Materials and methods), indicat-
ing that autoinhibition and the underlying 5-HT effl ux 
persist under conditions where fi ring activity, vesicular 
5-HT release, and SERT-mediated reuptake are abol-
ished. Under these conditions, the time course of Trp-
induced increase in GIRK conductance refl ects the 
time course of cytosolic 5-HT effl ux across the plasma 
membrane. The rate of GIRK conductance increase 
upon Trp application corresponds to the lower limit of 
5-HT release because the Trp-induced increase in GIRK 
conductance is a multistep process. In three recordings, 
data could be well fi tted with a single-exponential asso-
ciation function (R 2 = 0.92–0.98; see  Fig. 8 legend), re-
vealing that after a lag of 2–3 min upon the application 
of Trp, GIRK conductance increased at a mean time 
constant of 86.6 s (range of 82.3 to 89.0 s), indicating 
that 5-HT release occurs at least at the same rate. Simi-
lar results were obtained under control conditions, i.e., 
in the cocktail of synaptic blockers (  = 128.5 s; range 
of 89.7 to 193.5 s;  n = 3; e.g.,  Fig. 8 A ). As summarized 
in  Fig. 8 H , by using 5-HT1A autoreceptor-activated 
GIRK conductance as a 5-HT o sensor, we show that fi r-
ing activity is not required for autoinhibition and that 
substantial continuous effl ux of cytosolic 5-HT occurs 
in DRN. 
 Extracellular Ca 2+ and voltage-gated Ca 2+ channels 
(VGCCs) are not required for 5-HT effl ux 
 Because extracellular Ca 2+ is required for exocitotic 
neurotransmitter release, we wanted to examine depen-
dence of 5-HT effl ux in the DRN on extracellular Ca 2+ . 
Preliminary experiments showed that prolonged whole-
cell recordings from serotonergic neurons in Ca 2+ -free 
extracellular solution are not feasible as a result of of 
gradual developing of ohmic leak starting 20–30 min 
after establishing of whole-cell recording confi guration. 
Therefore, to test whether 5-HT effl ux can activate 
GIRK conductance in the absence of extracellular Ca 2+ , 
we applied briefer experimental protocols in which 
slices were perfused for at least 30 min before the start 
of the recording, with bath solution containing zero 
Ca 2+ (substituted with Mg 2+ ); 5.5 mM K + ; and the cocktail 
suppresses fi ring to an extent comparable with that to 
10 μM Tbz, while partially rescuing slice 5-HT content 
( Mlinar et al., 2005 ). Similar to the concentration–
response experiments, partial inhibition of SERT by 
citalopram suppressed fi ring less in the Tbz group than 
in the control group. However, under conditions where 
the bath solution contained 10 μM Trp, regardless of 
the presence of Tbz, the effect of citalopram was 
restored to near-control level (trend toward stronger 
effect in Trp group) and was signifi cantly stronger 
compared with the Tbz group (P = 0.0002; Kruskal–Wallis 
test; see  Fig. 7 C legend). These fi ndings support the 
hypothesis that the citalopram effect depends on cyto-
solic 5-HT levels and suggest that VMAT2-dependent 
vesicular 5-HT accumulation is not required for con-
tinuous 5-HT release unmasked upon the partial inhibi-
tion of SERT-mediated reuptake by citalopram. 
 Autoinhibition persists in the absence of neuronal fi ring 
 We next wanted to examine the dependence of autoin-
hibition and the underlying 5-HT effl ux on serotoner-
gic neuron fi ring, a question diffi cult to answer by using 
their fi ring rate as the monitored parameter. Given that 
the activation of 5-HT1A autoreceptors suppresses the 
fi ring of DRN serotonergic neurons primarily by activa-
tion of GIRK channels, to examine whether fi ring activ-
ity is required for 5-HT release, we investigated the 
effects of perturbation of endogenous 5-HT on 5-HT1A 
autoreceptor-activated GIRK current in the presence of 
TTX in whole-cell confi guration. Because the optimal 
conditions for whole-cell recording of GIRK current are 
different from those for the fi ring rate recording (thin-
ner slices, younger animals, lower temperature, higher 
[K + ] o , and the absence of phenylephrine), we fi rst tested 
whether 5-HT precursors, Trp and 5HTP, and the SSRI 
citalopram produce a measurable increase in GIRK 
conductance. In preliminary experiments performed in 
the synaptic blocker cocktail (e.g.,  Fig. 8, A and B ), sub-
stances that suppressed fi ring in cell-attached record-
ings produced an increase in GIRK conductance, which 
was reversed by the 5-HT1A receptor antagonist Way-
100635, indicating that 5-HT1A autoreceptor-activated 
GIRK channels can be used as a 5-HT o sensor. Because 
the effect of 30 μM Trp was at the threshold of detect-
ability in these recordings (0.25 ± 0.08 nS; mean ± SD; 
 n = 4), possibly because of reduced Tph2 activity, 
whereas 30 μM 5HTP and 0.2–1 μM citalopram consis-
tently increased GIRK conductance (see  Fig. 8 H , open 
bars), we also used the 5HTP challenge to elevate en-
dogenous 5-HT in whole-cell experiments, in addition 
to the Trp challenge. 
 We proceeded to investigate whether 5-HT release in 
the DRN depends on neural activity. Under conditions 
where neuronal fi ring activity was abolished by bath ap-
plication of 0.5 μM TTX, the application of 30 μM 
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 Figure 8. Use of 5-HT1A autoreceptor-activated GIRK channels of patched neuron as 5-HT o sensor reveals that fi ring activity is not 
required for autoinhibition. (A) Time course of a representative experiment under control conditions (cocktail of synaptic blockers, 
5.5 mM [K + ] o ; see Materials and methods) illustrating the effect of citalopram, coapplication of citalopram and Trp (+Trp), and 5-CT and 
the subsequent addition of Way-100635 (+Way) on inwardly rectifying K + conductance (G   110/  90mV ). 5-CT and Way-100635 were applied 
to determine maximal and zero 5-HT1A autoreceptor-activated GIRK conductance (G 5-HT1A ), respectively. In this and in subsequent 
fi gures showing time courses of whole-cell experiments, the sign + denotes the application of the compound in the continuous presence 
of preceding compounds, whereas time indicates duration of whole-cell confi guration. The red curve is the data fi t (from 26.5 to 35 min) 
with the function of the form G = G cita + (G Trp   G cita )(1   e  t/   ), where G is conductance and   is the exponential time constant 
(  = 193.5 s; 171–223 s 95% C.I.; R 2 = 0.982). (B) The current–voltage plot shows inwardly rectifying K + currents of the same experiment 
recorded before citalopram application (Bsl), in citalopram (Cita), after the addition of Trp, in 30 and 100 nM 5-CT, and after the 
addition of Way-100635 (Way; red trace). Traces are averages of the last 12 individual ramps recorded under the indicated conditions. 
(C) Time course of a representative experiment illustrating the effect of 1 μM citalopram and its antagonism after the addition of 50 nM 
Way-100635 (+Way) in the presence of 0.5 μM TTX. TTX was applied 3 min after establishing whole-cell confi guration after identifi ca-
tion of the neuron as serotonergic based on its properties in current clamp. Na + channel block by TTX was facilitated and verifi ed by 
periodic current injections that evoked action potential fi ring. (D) Current–voltage plot of the same experiment. Traces are averages of 
the last 12 individual ramps recorded before (Bsl) and during citalopram application (Cita), and the last six ramps recorded after the ad-
dition of Way-100635 (Way; red trace). (E) Current–voltage plot of net 5-HT1A autoreceptor-activated GIRK current (I 5-HT1A ) obtained 
by subtraction of Way-100635–insensitive current shows essentially no I 5-HT1A under baseline conditions and prominent activation in the 
presence of citalopram. (F) Time course of a representative experiment illustrating the effect of 1 μM citalopram and the subsequent 
addition of 30 μM Trp (+Trp) and 50 nM Way-100635 (+Way) in the presence of 0.5 μM TTX and 10 μM Tbz. The red curve is the data 
fi t (from 32 to 38 min) with the function described in A (  = 85.2 s; 77.1–95.2 s 95% C.I.; R 2 = 0.978). (G) Current–voltage plot of the 
same experiment. Traces are averages of 12 individual ramps, except for that in Way (six ramps; red trace). (H) Histogram summarizing 
5-HT1A autoreceptor-mediated activation of GIRK conductance by 30 μM Trp, 30 μM 5HTP, and 1 μM citalopram (Cita), and coapplica-
tion of 30 μM Trp and 1 μM citalopram (Trp + Cita) in the synaptic blocker cocktail (open bars;  n = 4, 4, 8, and 6) and in the presence 
of TTX or TTX and Tbz (pooled data, closed bars;  n = 6, 3, 6, and 6). In individual experiments, G 5-HT1A values for the substances applied 
were obtained by subtracting the mean of G   110/  90mV values measured in baseline and in 50 nM Way-100635. The dotted line indicates 
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in Ca 2+ -free solution. Thus, 5-HT release persisted under 
conditions where, in addition to abolished fi ring activity 
and vesicular 5-HT accumulation, extracellular solution 
was devoid of Ca 2+ or contained Cd 2+ , preventing Ca 2+ 
entry through VGCCs. Collectively, these fi ndings fur-
ther strengthened the conclusion that substantial non-
exocitotic 5-HT effl ux occurs in the DRN. 
 5-HT effl ux from a neuron does not signifi cantly contribute 
to its own autoinhibition 
 We next investigated the origin of 5-HT underlying 
autoinhibition in the DRN. To examine a possible con-
tribution of 5-HT effl ux from an individual serotoner-
gic neuron to autoinhibition, we performed a series of 
experiments in which inwardly rectifying K + conduc-
tance was measured under conditions where 5-HT or its 
intermediate precursor, 5HTP, was included in the pi-
pette solution ( Fig. 10 ). Because the exact concentration 
of synaptic blockers, 0.5 μM TTX, 10 μM Trp, and 
10 μM Tbz. Under these conditions, block of 5-HT up-
take by bath application of 1 μM citalopram during the 
recording (15–18 min;  n = 6;  Fig. 9, A and B ) or before 
the establishment of whole-cell recording confi guration 
(25–30 min;  n = 3;  Fig. 9 C ) produced a clear activation 
of 5-HT 1A receptor-activated GIRK conductance, as re-
vealed by the subsequent addition of 20 nM Way-100635 
(10–12 min;  Fig. 9 D ). Because Ca 2+ -free extracellular 
solution used in these experiments contains low micro-
molar Ca 2+ (contamination from MgCl 2 and glassware), 
we also examined whether VGCCs are required for 
5-HT effl ux. As shown in  Fig. 9 (E–H) , in recordings 
with bath solution containing 100 μM of nonselective 
VGCC blocker Cd 2+ (CdCl 2 ), 5.5 mM K + , and the cocktail 
of synaptic blockers (0.5 μM TTX, 10 μM Trp, and 
10 μM Tbz), the application of 1 μM citalopram activated 
GIRK conductance to an extent similar to that observed 
 Figure 9. Extracellular Ca 2+ is not required for autoinhibition. (A–D) Experiments in Ca 2+ -free extracellular solution. (A) Time course 
of a representative experiment ( n = 6) illustrating the effect of 1 μM citalopram and its antagonism after the addition of 20 nM Way-
100635 (+Way) in Ca 2+ -free extracellular solution, containing the cocktail of synaptic blockers: 5.5 mM [K + ] o , 0.5 μM TTX, 10 μM Tbz, 
and 10 μM Trp. (B) The current–voltage plot of the same experiment. Traces are averages of the last nine individual ramps recorded 
before citalopram application (Bsl), in citalopram (Cita), and after the addition of Way-100635 (Way; red trace). Downward shift of 
the trace in Way in respect to the Bsl was caused by the gradual increase in leak, typical for recordings in Ca 2+ -free extracellular solu-
tion. (C) Time course of a representative experiment ( n = 3) in which 1 μM citalopram was applied 30 min before obtaining whole-cell 
recording confi guration, permitting the completion of the experiment under leak-free conditions. (D) Scatter plot summarizing the 
magnitude of 5-HT 1A autoreceptor-mediated activation of GIRK conductance by 1 μM citalopram in Ca 2+ -free extracellular solution. 
Error bars correspond to mean ± SD. The addition of Way-100635 in the continuous presence of citalopram decreased inwardly rectify-
ing K + conductance by 2.86 ± 1.93 nS (mean ± SD;  n = 9; P = 0.0011; one-tailed paired  t test; normal distribution; P = 0.07; D’Agostino and 
Pearson omnibus test). (E–H) Experiments in the presence of the nonselective VGCC blocker Cd 2+ . (E) Time course of a representative 
experiment in extracellular solution containing the cocktail of synaptic blockers: 5.5 mM [K + ] o , 0.5 μM TTX, 10 μM Tbz, 10 μM Trp, 
and 100 μM CdCl 2 . (F) The current–voltage plot of the same experiment. Traces are averages of 13 individual ramps recorded under 
the indicated conditions. (G) Current–voltage plot of net 5-HT1A autoreceptor-activated GIRK current (I 5-HT1A ) of the same experiment. 
The trace in Way-100635 is shown in red. (H) Scatter plot summarizing the magnitude of 5-HT 1A autoreceptor-mediated activation of 
GIRK conductance by 1 μM citalopram in Cd 2+ -containing extracellular solution. Bars correspond to mean ± SD. The addition of 20 μM 
Way-100635 decreased inwardly rectifying K + conductance by 2.66 ± 1.35 nS (mean ± SD;  n = 8; P = 0.0004; one-tailed paired  t test; normal 
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 Figure 10. Effl ux of 5-HT from a serotonergic neuron does not contribute signifi cantly to its autoinhibition. (A) Time course of a rep-
resentative experiment in which the pipette solution contained 100 μM 5HTP. Inwardly rectifying K + conductance, determined from the 
slope of recorded current in the range from   110 to   90 mV (G   110/  90mV ) was constant during the fi rst 10 min of the recording. Bath 
application of 30 μM 5HTP, indicated by the horizontal bar, produced a clear increase in G   110/  90mV , which was completely reversed 
by the subsequent addition of Way-100635 (+Way). Interruptions in data correspond to passage into current-clamp mode for electro-
physiological identifi cation of the recorded neuron (see Materials and methods). (B) Current–voltage plot shows inwardly rectifying 
K + currents of the same experiment recorded before (a) and after (b) bath application of 5HTP, and after the coapplication of 5HTP and 
Way-100635 (c; red trace). Traces are averages of the last six individual ramps recorded in the indicated conditions. (C) Current–voltage 
plot obtained by subtraction of Way-100635–insensitive current shows lack of 5-HT1A autoreceptor-activated GIRK current activation by 
intracellularly applied 5HTP and prominent activation by the bath application. (D) Time course of a representative experiment in which 
the pipette solution contained 300 nM 5-HT. Bath solution contained 10 μM Tbz. Horizontal bars indicate bath application of 5HTP 
and coapplication of 5HTP and Way-100635 (+Way). (E) Current–voltage plot of experiment shown in D. Traces are averages of 15 in-
dividual ramps. (F) Current–voltage plot obtained by subtraction of Way-100635–insensitive current shows lack of 5-HT1A autoreceptor-
activated GIRK current (I 5-HT1A ) activation by intracellularly applied 5-HT and its activation by the bath application of 30 μM 5HTP. 
(G) Histogram summarizing the effect of the intracellular application of 5-HT or 5HTP on the baseline G   110/  90mV , measured at steady state, 
10–15 min after establishing whole-cell confi guration. The two-tailed Kruskal–Wallis test indicated a signifi cant difference (P = 0.0105), 
but the only signifi cant difference was between 300 μM 5-HT in Tbz and 3 mM 5-HT in Tbz groups (P < 0.01; Dunn’s multiple compari-
son post-hoc test). (H) Time course of a representative experiment with 3 mM 5-HT in the pipette and bath application of Way-100635 
(Way). (I) Current–voltage plot of experiment shown in H. Traces are averages of 12 individual ramps. (J) Current–voltage plot of the 
net Way-100635–sensitive current. (K) Scatter plot summarizing the magnitude of Way-100635–sensitive current in experiments with 
3 mM 5-HT in the pipette and bath solution containing ACSF cocktail (Ctrl) or ACSF cocktail plus 10 μM Tbz (+Tbz). Bars correspond to 
mean ± SD. The decrease in inwardly rectifying K + conductance by Way-100635 did not reach signifi cance in individual groups (P = 0.063 
and 0.078; one-tailed Wilcoxon matched-pairs test), whereas the analysis of pooled data indicated a signifi cant decrease (P = 0.0034; 
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presence of a SERT inhibitor, as that would not discrimi-
nate if 5-HT originated from the patched or from surround-
ing neurons. To overcome these limitations, experiments 
were done on raphe slices obtained from Tph2 knockout 
(Tph2   /   ) mice. To examine if there is detectable 5-HT 
release from a loaded neuron when SERT is inhibited, 
we loaded 3 mM 5-HT in serotonergic neurons of 
Tph2   /   mice and compared GIRK conductance in the 
presence of 1 μM citalopram and after the application of 
50 nM Way-100635 ( Fig. 11 ). The citalopram application 
itself did not signifi cantly change inwardly rectifying K + 
conductance (0.55 ± 1.14 nS; mean ± SD;  n = 6; P = 0.56; 
two-tailed Wilcoxon matched pairs test), and variable re-
sponses were observed in individual experiments, com-
prising both increase and decrease (e.g.,  Fig. 11, A and E ; 
range of   0.38 to 2.28 nS), consistent with the dual ef-
fect of SERT inhibition on both 5-HT effl ux from the 
loaded neuron through reverse transport and the uptake 
in surrounding neurons. In 3 mM 5-HT–loaded seroto-
nergic neurons from Tph2   /   mice, inhibition of 
5-HT1A autoreceptors by the addition of Way-100635 
in the continuous presence of citalopram decreased in-
wardly rectifying K + conductance by 1.69 ± 0.90 nS (mean 
± SD;  n = 8; P = 0.0006; one-tailed paired  t test; normal 
distribution; P = 0.68; D’Agostino and Pearson omnibus 
test) revealing a SERT-independent release of 5-HT from 
a single serotonergic neuron. Because these recordings 
were done in the synaptic blocker cocktail and recorded 
neurons were held at   65 mV, the release was occurring 
in the absence of fi ring activity. In addition, there was no 
change in GIRK conductance even in response to sus-
tained fi ring induced by current injections in current 
clamp ( n = 6; not depicted), further supporting the non-
exocytotic origin of 5-HT o . 
 As to whether cytosolic 5-HT effl ux from a serotonergic 
neuron contributes to its autoinhibition, experimental re-
sults in slices obtained from Tph2   /   mice were similar to 
those observed in the rat. In Tph2   /   mice, a bath perfu-
sion of 30 μM 5HTP produced more substantial activation 
of GIRK channels than cell loading with a much higher 
concentration of 5HTP or 5-HT (e.g.,  Fig. 11 E ; represen-
tative of three experiments). In recordings in which the 
pipette solution contained 1 mM 5HTP, aiming to maxi-
mally induce 5-HT synthesis in the recorded cell, the leak-
age of 5HTP from the pipette tip before the gigaseal 
formation produced notable GIRK current at the begin-
ning of whole-cell recording, which then faded away com-
pletely over the course of the recording ( Fig. 11, F and G ; 
representative of four experiments), suggesting the inter-
neuronal nature of autoinhibition. 
 Firing suppression is mediated by 5-HT release from 
surrounding neurites 
 Finally, because fi ndings of whole-cell experiments indi-
cated that 5-HT o underlying autoinhibition of a given 
serotonergic neuron originates principally in surrounding 
of 5-HT normally present in the cytosol is unknown, we 
used 5-HT at concentrations of 0.3 and 3 mM, assumed 
to be one to two orders of magnitude higher than nor-
mal, based on the rationale explained in Materials and 
methods. Similarly, 5HTP was applied at 0.1 and 1 mM, 
concentrations expected to partially and nearly com-
pletely saturate AADC in the recorded neuron, given 
that AADC K m for 5HTP is   18–66 μM ( Rahman et al., 
1981 ;  Jebai et al., 1997 ). In these experiments, 
after establishment of gigaseal, the cell-attached con-
fi guration was typically maintained for 5–7 min before 
rupturing the patch to allow for washout of 5-HT or 
5HTP, which leaked out from the pipette tip. Loading 
of the recording neuron with 0.1 or 1 mM 5HTP (e.g., 
 Fig. 10, A–C ) or 300 μM 5-HT (e.g.,  Fig. 10, D–F ) did 
not produce a detectable increase in inwardly rectifying 
K + conductance, which was however reliably induced in 
the same experiments by bath perfusion with 30 μM 
5HTP, suggesting that 5-HT o originated primarily from 
surrounding serotonergic neurons. In a subgroup of 
experiments with 5-HT loading, the bath solution also 
contained 10 μM Tbz. A comparison of baseline in-
wardly rectifying K + conductance, recorded 10–15 min 
after establishing the whole-cell confi guration to ensure 
thorough loading of the recorded neuron and com-
plete washout of 5HTP or 5-HT leaked from the pipette 
before establishing gigaseal, did not reveal signifi cantly 
increased intracellular 5HTP or 5-HT ( Fig. 10 G ). 
A small effl ux of 5-HT from serotonergic neurons was 
revealed only in experiments in which the patch pipette 
contained a high (3 mM) 5-HT concentration, and in 
which, after a stable G   110/  90mV baseline, the addition 
of Way-100635 decreased G   110/  90mV ( Fig. 10, H–K ). 
Again, similar results were obtained regardless of the 
presence of Tbz, consistent with the nonvesicular na-
ture of 5-HT release. An analysis of pooled data revealed 
that when a cell is loaded with 3 mM 5-HT, the appli-
cation of Way-100635 decreased inwardly rectifying K + 
conductance by 0.52 ± 0.47 nS (mean ± SD;  n = 10; P = 
0.0034; one-tailed paired  t test), revealing an effl ux of 
5-HT under these conditions. 
 Experiments involving intracellular application of 
5-HT and 5HTP suggested that effl ux of cytosolic 5-HT 
from a given serotonergic neuron does not contribute 
signifi cantly to the autoinhibition of that neuron. How-
ever, these fi ndings might have been infl uenced by SERT 
activity in two opposing ways. First, it is possible that 5-HT 
effl ux from a 5HTP- or 5-HT–loaded neuron remained 
undetected, i.e., did not produce measurable GIRK 
channel activation caused by the concurrent removal of 
5-HT o by SERT located on surrounding serotonergic 
neurons. Second, it is possible that after the loading of a 
neuron with 3 mM 5-HT, the effl ux of 5-HT responsible 
for 5-HT1A autoreceptor-mediated GIRK channel activa-
tion is in some part caused by SERT reversal. It was not 
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cases interfered with the recording, causing a tissue dis-
placement artifact and preventing a comparison of ef-
fects compared with distance. Spritzes into areas located 
≥40 μm lateral to the recorded neuron were, however, 
reliable and permitted observation of the effect’s time 
course. Spritzes of 1 mM Trp into areas largely devoid 
of cell bodies, located 40–50 μm lateral to the recorded 
neuron, after a lag of   20 s, rapidly suppressed the fi r-
ing rate ( Fig. 12 D ), indicating that [5-HT] o concentra-
tion in the DRN is tightly controlled by the cytosolic 
5-HT concentration in surrounding serotonergic den-
drites and/or axons. 
 To alternatively achieve focal 5-HT precursor delivery 
to the cell body of recorded neuron without pressure ejec-
tion, we did a series of experiments in which loose-seal 
serotonergic neurons, we wanted to confirm that 
the same holds true for the suppression of fi ring in in-
tact serotonergic neurons in a more physiologically rel-
evant setting. Thus, while recording the fi ring rate in 
the loose-seal cell-attached mode, Trp or 5HTP was fo-
cally applied to the slice at different lateral distances 
from the recorded neuron by using long-duration 
(3–6 min) pressure ejection with a picospritzer ( Fig. 12 ). 
Focal application of 1 mM Trp 40–100 μm lateral of the 
recorded neuron suppressed fi ring comparable to (e.g., 
 Fig. 12, A and B ;  n = 3) or stronger ( n = 2) than the focal 
somatic application. Similar results were obtained with 
1 mM 5HTP ( n = 3; e.g.,  Fig. 12 C ). Focal application by 
pressure ejection from the pipette positioned close to 
or directly over the recorded neuron cell body in most 
 Figure 11. The effect of 5-HT effl ux from a single neuron 
in slices obtained from Tph2   /   mice. (A) Time course 
of a representative experiment with 3 mM 5-HT in the 
pipette solution and bath application of 1 μM citalopram 
(Cita), followed by coapplication of 1 μM citalopram and 
50 nM Way-100635 (+Way). Inwardly rectifying K + conduc-
tance (G   110/  90mV ) was determined from the slope of re-
corded current in range from   110 to   90 mV. Notable 
G   110/  90mV decaying during the fi rst 10 min of the record-
ing was caused by the activation of 5-HT1A autoreceptors, 
caused by the leakage of 5-HT from the pipette tip before 
the formation of gigaseal. (B) Current–voltage plot shows 
inwardly rectifying K + currents of the same experiment re-
corded after establishing whole-cell confi guration (a), at 
the steady-state level before citalopram application (b), in 
citalopram (c), and in citalopram plus Way-100635 (d; red 
trace). Traces represent averages of three (a) or six indi-
vidual ramps (b–d). (C) Current–voltage plot obtained by 
subtraction of Way-100635–insensitive current. (D) Scat-
ter plot of magnitude of Way-100635–sensitive conduc-
tance in the presence of citalopram in experiments with 
3 mM 5-HT in the pipette. Bars correspond to mean ± SD. 
(E) Time course of an experiment showing the effects of 3 mM 
5-HT in the pipette and bath applications of citalopram 
(Cita), citalopram and 5HTP (+5HTP), and the addition 
of Way-100635 (+Way), suggesting that 5-HT o originates 
primarily from surrounding neurons. (F) Time course of 
a representative experiment in which the pipette solution 
containing 1 mM 5HTP shows marked inwardly rectifying 
K + current at the beginning of the recording, which faded 
away over the course of the recording. (G) Current–voltage 
plot of experiment shown in F. Traces are averages of 
six individual ramps recorded during the 2nd and the 
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was not suppressed by 5-HT precursors and, in experi-
ments with 5HTP in the recording pipette solution, the 
fi ring rate was actually increasing during the fi rst 2–5 min 
of recording, indicative of the 5HTP leakage out of 
the pipette before establishing loose-seal confi guration. 
cell-attached recording was done with pipettes con-
taining 1 mM Trp or 5HTP ( Fig. 12 E ). In these 
experiments, pipettes had a large-bore tip (R pip of ≈1.7–
2.1 MΩ) to increase the contact area with the recorded 
neuron. Contrary to spritz experiments, the fi ring rate 
 Figure 12. 5-HT–mediating suppression of fi ring originates in surrounding neurites. (A) Time course of representative experiment in 
which 1 mM Trp was spritzed 45 μm lateral, 90 μm lateral and directly toward the recorded neuron. (B) Photographs showing recorded 
neuron, recording pipette (R), and spritz pipette (S) arrangement for the experiment shown in A. (C) Time course of a representa-
tive experiment in which 1 mM 5HTP was spritzed 80 μm lateral and directly toward the cell body of the recorded neuron. Transient 
decrease in the fi ring rate at the end of the cell body–directed pulses is an artifact of tissue movement. (D) Average time course for 
experiments in which 1 mM Trp was spritzed 40–50 μm lateral to the recorded neuron ( n = 8). Symbols represent the mean ± SD of the 
normalized, binned fi ring rate, expressed as absolute difference in the baseline fi ring rate computed over the 5 min preceding Trp ap-
plication in each experiment. Shaded area corresponds to the spritz duration. Right, the onset of Trp-induced change on an enlarged 
scale. Red curve is a data fi t of means with the function of the form Y = {0, if t < lag; Y Trp (  1 + e   (t      lag)/   ), if t ≥ lag}, where lag is time 
from the application of Trp to the beginning of change,   is the exponential time constant, and Y Trp is the change in fi ring rate when 
steady-state level is achieved (lag = 19.6 s; 13.8–25.3 s 95% C.I.;   = 24.7 s; 17.7–40.8 s 95% C.I.; Y Trp = 0.27 Hz; 0.26–0.29 Hz 95% C.I. Hz; 
R 2 = 0.969). (E–G) Direct somatic application of Trp and 5HTP with the recording pipette did not change the fi ring rate of the recorded 
serotonergic neuron. (E) Average time course for loose-seal cell-attached recordings in which 1 mM Trp or 1 mM 5HTP was included 
in the recording pipette solution. (F) Time course of an experiment in which the recorded neuron was rapidly approached with the 
second, nonrecording wide-tip patch pipette (R pip = 1.9 MΩ) containing 1 mM 5HTP during recording with 5-HT precursor-free pipette 
solution. The red line represents the distance between tip of the pipette and the neuron. Positive pressure was applied to the 5HTP-
containing pipette for 30 s, indicated by the shaded area. (G) Photograph of experiment in F taken during the period when both the 
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refl ects a dynamic equilibrium among 5-HT synthesis, 
degradation, vesicular storage, release, and uptake 
( Fig. 13 ). Inhibition of SERT-mediated uptake is suffi cient 
to considerably elevate [5-HT] o in the DRN, indicating 
that the activity of SERT compensates for substantial 
continuous 5-HT release under physiological condi-
tions. In this study, we aimed to identify the origin of 
basal 5-HT o in the DRN and the underlying mechanism 
of release. 
 A widely held assumption that 5-HT release from axo-
nal collaterals supplies basal 5-HT o and causes auto-
inhibition ( Albert et al., 2011 ;  Altieri et al., 2013 ) is 
supported by early electrophysiological studies that re-
vealed that serotonergic inhibitory postsynaptic poten-
tials can be evoked in serotonergic neurons ( Yoshimura 
and Higashi, 1985 ;  Williams et al., 1988 ;  Pan et al., 
1989 ). Our data confi rmed the existence of IPSP/C 5-HT 
but also suggested that they are not a prominent feature 
of the DRN, as strong electrical stimulation of nearby 
(  200-μm) tissue, particularly in the rostral extension 
of the DRN, often failed to evoke IPSP/C 5-HT in seroto-
nergic neurons. In addition, evoked IPSC 5-HT had rather 
The bath application of 50 nM Way-100635 at the end 
of these recordings did not change the fi ring rate ( n = 3; 
not depicted). In a fi nal series of experiments, during 
fi ring rate recording by using 5-HT precursor-free pi-
pette solution, focal 5HTP application was achieved by 
rapidly advancing a second, 5HTP-containing pipette 
(1 mM) until it touched the recorded neuron soma 
( Fig. 12, F and G ; representative of four experiments). 
Again, the fi ring rate was insensitive to focal somatic 
delivery of 5HTP. Collectively, these fi ndings confi rm 
those of the whole-cell recordings, which indicate the 
interneuronal nature of autoinhibition and suggest that 
5-HT o in the DRN primarily originates from surround-
ing serotonergic neurites. 
 D I S C U S S I O N 
 The mechanisms regulating basal [5-HT] o in serotoner-
gic nuclei are important because they determine the 
extent of 5-HT1A autoreceptor-mediated autoinhibi-
tion and thus the activity of the entire serotonergic sys-
tem. The concentration of 5-HT o present in the DRN 
 Figure 13. Schematic summary of 
metabolic and transmembrane 5-HT 
pathways in the DRN. In serotoner-
gic cell bodies, 5-HT is synthesized de 
novo from Trp, an essential amino acid 
derived from food. Trp is converted 
to 5HTP by Tph2, the rate-limiting 
enzyme in 5-HT synthesis, which re-
quires tetrahydrobiopterin (BH 4 ) as 
an essential cofactor. The intermediate 
meta bolite 5HTP is rapidly converted 
to 5-HT by cytosolic AADC. Excessive 
cytosolic 5-HT is principally degraded 
by mitochondrial MAOB via conver-
sion into 5-hydroxyindolealdehyde 
(5-HIAL), which is further converted into 
5-hydroxyindoleacetic acid (5-HIAA) 
by aldehyde dehydrogenase type 
2 (Aldh2). 5-HT is loaded from the 
cytosol into secretory vesicles by VMAT2. 
Vesicular 5-HT can be exocytotically 
released either in the proximity of cell 
bodies or, after the transport of vesicles 
along axons, in projection areas. Find-
ings in this study indicate the existence 
of substantial nonexocytotic effl ux of 
5-HT across the plasma membrane, re-
sulting in [5-HT] o suffi cient to partially 
activate somatodendritic 5-HT1A auto-
receptors. Extracellular 5-HT is taken 
back into serotonergic neurons by 
SERT, mostly into axons, where SERT 
is predominantly located ( Tao-Cheng 
and Zhou, 1999 ). Red lines represent 
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caused by a reduced level of its essential cofactor tetra-
hydrobiopterin ( Sawada et al., 1986 ;  Liu et al., 2005 ); 
and a decreased number of intact neurites from which 
5-HT o apparently originates. Nevertheless, the extent of 
fi ring suppression produced by Trp challenge was suf-
fi cient for the scope of this study, and because this ef-
fect of Trp is fully dependent on 5-HT1A autoreceptors 
and neuronal Tph2, we consider the Trp challenge to 
be an appropriate tool for studying the mechanisms 
regulating basal [5-HT] o . We show that the fi ring sup-
pression induced by 30 μM Trp is independent of GABA 
and glutamate transmission. Thus, although GABAergic 
( Liu et al., 2000 ;  Tao and Auerbach, 2003 ) and gluta-
materic ( De Kock et al., 2006 ;  Colgan et al., 2012 ) 
transmission in the DRN can infl uence serotonergic 
neuron activity, they do not contribute to the autoinhi-
bition. Similarly, 5-HT1A autoreceptor-mediated fi ring 
suppression induced by 30 μM Trp is not dependent on 
5-HT accumulation in synaptic vesicles, indicating the 
cytosolic origin of 5-HT o in the DRN. It is noteworthy 
that the increase in cytosolic 5-HT concentration, pro-
duced by Trp challenge, can cause an increase in 
[5-HT] o and thus autoinhibition not only by increasing the 
release rate but also by decreasing the reuptake rate 
caused by increased 5-HT gradient across the plasma 
membrane. Therefore, the [5-HT] o directly refl ects the 
cytosolic 5-HT concentration and is largely indepen-
dent of vesicular 5-HT. The release of 5-HT that main-
tains basal [5-HT] o can be detected under conditions of 
inhibited uptake. Thus, in experiments done in Trp-
free ACSF, the block of SERT produced a marked sup-
pression of fi ring, revealing substantial 5-HT release, 
even under conditions of subphysiological cytosolic 
5-HT level. Marked suppression of fi ring by SERT block 
was also observed when 5-HT accumulation in synaptic 
vesicles was prevented by VMAT2 inhibition, confi rm-
ing that the basal [5-HT] o is maintained by nonexocy-
totic 5-HT release. 
 Further characteristics of 5-HT release were revealed 
by using 5-HT1A autoreceptor-activated GIRK channels 
of patched serotonergic neurons as a sensor of 5-HT o . 
In these experiments, the increase in [5-HT] o induced 
by the Trp challenge was at the limit of detection, but 
when unmasked under the SERT block, 30 μM of Trp-
induced 5-HT release produced an increase in GIRK 
conductance of typically   1–3 nS, corresponding to an 
estimated increase in [5-HT] o of   30–90 nM. These ex-
periments reveal that the fi ring activity is not required 
for the underlying release and confi rm the presence of 
considerable basal nonexocytotic 5-HT release in the 
DRN. We also show that the increase in [5-HT] o pro-
duced via SERT block by SSRI citalopram, apart from 
higher magnitude, has properties comparable to the in-
crease induced by Trp challenge. Thus, we observed a 
prominent citalopram-induced increase in GIRK conduc-
tance both under basal conditions and under conditions 
small maximal amplitude values, with a median of 
  7 pA at the holding potential of   60 mV. These fi nd-
ings apparently contrast with previous studies reporting 
somewhat bigger responses, but the difference can be 
explained by less restrictive experimental conditions in 
previous studies. Namely, bigger responses could be, at 
least in part, attributed to the GABAB/GIRK-mediated 
synaptic transmission, as GABAB receptor antagonists 
were not used in early studies, and to multisynaptic 
mechanisms because, with the exception of the study by 
 Pan et al. (1989) , the recordings were done in the ab-
sence of any glutamate and GABA receptor antagonists. 
However, our fi ndings are consistent with the anatomi-
cal evidence of scarce axonal 5-HT input in the DRN 
( Descarries et al., 1982 ), suggesting that relatively in-
conspicuous functional serotonergic synaptic transmis-
sion may be a general property in the DRN. In addition, 
given the paracrine characteristics of evoked serotoner-
gic transmission ( Bunin and Wightman, 1998 ;  Bunin 
et al., 1998 ) and the abundance of SERT in the DRN 
( Qian et al., 1995 ), rapid removal of 5-HT o by SERT 
conceivably contributes to the effects observed. Thus, 
although serotonergic synaptic transmission in the 
DRN could have a functional role, and in spite of the 
possibility that it is signifi cantly reduced in slice prepa-
ration caused by the severing of serotonergic axons, the 
relative paucity of serotonergic synaptic transmission in 
the DRN supports our principal fi ndings (see below), 
suggesting that conventional exocytotic 5-HT release is 
not required for the maintenance of basal [5-HT] o . 
 We examined the mechanism of basal 5-HT release in 
the DRN by measuring the suppression of the seroto-
nergic neuron fi ring rate in response to Trp challenge. 
To emulate in brain slice preparation the noradrener-
gic drive that during wakefulness exerts a maximal ef-
fect on serotonergic neuron fi ring ( Levine and Jacobs, 
1992 ), experiments were done in the presence of   1 
agonist phenylephrine. To reproduce the extent of au-
toinhibition matching that of the awake state, we used 
Trp at 30 μM, the concentration that restores 5-HT con-
tent in slices approximately to its level immediately after 
slicing ( Mlinar et al., 2005 ). This concentration is in the 
range of Trp content in brain tissue, generally estimated 
to be 10–40 μM, although higher than that (6.7 μM) 
measured in the third ventricle cerebrospinal fl uid in 
freely moving rat ( Chaouloff et al., 1986 ). The extent of 
autoinhibition produced by 30 μM Trp in this study, on 
average   0.4 Hz or   25% reduction in the fi ring rate, 
is lower than that revealed by Way-100635 application 
in anesthetized rats,   0.9 Hz or   37–47% ( Hajós et al., 
2001 ;  Haddjeri et al., 2004 ), and in awake cats,   1.2 Hz 
or 40% ( Fornal et al., 1996 ). The weaker autoinhibition 
observed in slice preparations can be attributed to sev-
eral factors such as: the presence of weak autoinhibi-
tion, even in the absence of Trp ( Corradetti et al., 










Published February 23, 2015
246  Nonexocytotic 5-HT release mediates autoinhibition 
DRN, potential release mechanisms from the cytosolic 
pool were considered. The leakage of 5-HT from neu-
rons damaged during slice preparation is unlikely be-
cause recordings were done on neurons located ≥40 μm 
from the slice surface, and 5-HT precursors as well as 
SERT blockers produce weaker effects in superfi cial 
neurons ( Mlinar et al., 2005 ), the opposite of what 
would occur if 5-HT leaked out of damaged neurons. 
Next, the possibility that the release of cytosolic 5-HT 
occurs by reversal of SERT transport can be ruled out 
because 5-HT effl ux persists in the presence of saturat-
ing concentration of citalopram. That SERT is not re-
quired for the release is also suggested by the fi nding 
that the application of 5-HT precursors suppresses fi r-
ing of serotonergic neurons in slices obtained from 
SERT knockout (Sert   /   ) mice comparable to that 
from control animals ( Araragi et al., 2013 ). Another 
potential nonexocytotic 5-HT release mechanism is 
through polyspecifi c organic cation transporters, such 
as organic cation transporters 1–3 and plasma mem-
brane monoamine transporter, which have affi nity for 
5-HT in micromolar to low millimolar range and are 
able to translocate 5-HT across the plasma membrane 
in either direction ( Engel et al., 2004 ;  Amphoux et al., 
2006 ;  Koepsell et al., 2007 ). However, none of these 
transporters seems to be consistently expressed in sero-
tonergic neurons. 5-HT could also potentially leak out 
of the cytosol through a large cation channel, e.g., 
through connexin or pannexin hemichannels. To our 
knowledge, no such channel is expressed in DRN sero-
tonergic neurons. 
 Finally, 5-HT could cross the plasma membrane by 
passive diffusion, a mechanism generally assumed as 
improbable in underlying 5-HT release ( Hensler, 2012 ), 
given that at physiological pH, 5-HT is predominately in 
its protonated form (5-HTH + ), and charged molecules 
do not easily partition the membrane. However, it has 
recently been shown ( Peters et al., 2013 ) that, unusually 
for a hydrophilic solute, 5-HT partitions strongly in 
lipid bilayers, having a distribution coeffi cient (D x 
or P app,x of ≈1,200 for dimyristoylphosphatidylcholine 
bilayers; in mole fraction units) comparable to that of 
highly hydrophobic compounds,   100 times higher 
than the partitioning coeffi cient of neutral 5-HT form 
for bulk lipid–water mixtures (P x 0f ≈10.8 for octanol–
water mixtures), and >10 5 times higher than that of pro-
tonated 5-HT (P “true”,x of ≈0.04 for water–nitrobenzene 
interface;  Tatsumi and Ueda, 2011 ). Consistently, the 
hypothesis that simple diffusion could underlie 5-HT 
release in the DRN is further supported by the observa-
tion that diffusion of 5-HT from phosphatidylcholine 
vesicles occurs with the mean lifetime (or time constant,   ) 
of   70 s and the permeability coeffi cient of   4.8 × 10   8 
cm s   1 ( Berry et al., 2013 ). Although passive diffusion of 
5-HT across the plasma membrane has not been shown 
in serotonergic neurons, it has been demonstrated 
of abolished fi ring activity, Ca 2+ infl ux and 5-HT 
accumulation in synaptic vesicles. These fi ndings indi-
cate that not only basal [5-HT] o but also elevated 
[5-HT] o induced by SSRI antidepressant treatment are 
maintained by an activity-independent nonexocytotic 
mechanism. This conclusion is further supported by ex-
periments in which the endogenous 5-HT level was ele-
vated by application of the intermediate 5-HT precursor, 
5HTP, which can increase the rate of 5-HT synthesis 
above its physiological level, as the rate-limiting step in 
5-HT synthesis is bypassed. Characteristics of 5HTP-
induced autoinhibition were comparable with that 
induced by Trp, i.e., nonexocytotic and activity- and 
SERT-independent, indicating that in the DRN, 5-HT 
release under conditions of supraphysiological levels of 
endogenous 5-HT is mediated by the same mechanism 
as basal release. 
 Given the cytosolic origin of 5-HT o , we examined the 
possibility that autoinhibition is caused by 5-HT o origi-
nating in the autoinhibited neuron itself. Several fi nd-
ings of this study indicate that 5-HT o underlying 5-HT1A 
autoreceptor-mediated autoinhibition does not origi-
nate in the autoinhibited neuron but in surrounding 
serotonergic neurons and/or serotonergic neurites 
that permeate the DRN. First, whole-cell recordings in 
which high concentrations of 5-HT or 5-HTP are intra-
cellularly applied by the recording pipette suggest that 
an individual serotonergic neuron can be only margin-
ally autoinhibited by 5-HT originating in that neuron. 
Considering the possibility that intracellular loading 
did not maximally increase 5-HT in the most distal neu-
rites, these experiments clearly show that at least so-
matic and perisomatic 5-HT effl ux from a given neuron 
does not underlie its autoinhibition. Second, cell-at-
tached recordings in which high concentrations of Trp 
or 5HTP are included in the recording pipette or in 
another, closely positioned pipette further suggest that 
the neuron does not inhibit itself. Third, cell-attached 
recordings in which Trp or 5HTP are applied by pres-
sure ejection from a spritz pipette suggest that 5-HT 
originates in surrounding serotonergic neurons, pri-
marily in the dense network of neurites surrounding 
serotonergic cell bodies. 
 The lack of dependence of autoinhibition on 5-HT 
accumulation in synaptic vesicles strongly suggests that 
exocytotic release is not required for the supply of 
5-HT o in the DRN. It would still be possible that even 
under conditions of inhibited VMAT2 or V-ATPase, re-
cycling of vesicles with residual 5-HT can to some extent 
suppress fi ring and activate GIRK channels. However, 
no indications of such a mechanism were observed. For 
example, regardless of whether 5-HT accumulation in 
secretory vesicles is inhibited or not, the magnitude and 
the kinetics of the GIRK conductance activation upon 
citalopram or Trp application are similar. Having ex-
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has been shown at the neuromuscular junction under 
resting conditions ( Katz and Miledi, 1977 ). Impor-
tantly, passive diffusion across the plasma membrane of 
intact cells has been shown for other monoamine trans-
mitters, e.g., dopamine ( Kim et al., 2000 ;  Scholze et al., 
2001 ), and effl ux of dopamine and especially noradren-
aline from phosphatidycholine vesicles has been shown 
to occur at a higher rate compared with 5-HT ( Berry 
et al., 2013 ). As all monoamine transmitters have a high 
transmembrane gradient established by respective high 
affi nity plasma membrane transporters, it can be hy-
pothesized that simple diffusion of monoamine trans-
mitters across the plasma membrane may be a signifi cant 
component of their release. In particular, because brain 
monoamine systems are under regulatory control by 
negative feedback analogous to that of serotonergic sys-
tem, and because monoaminergic nuclei characteristi-
cally contain a network of monoaminergic neurites, it is 
possible that transmembrane diffusion contributes to 
autoinhibition of monoaminergic neurons in general. 
 Autoinhibitory regulation of the serotonergic system 
at the level of serotonergic nuclei has remained unclear 
in spite of numerous studies investigating the function 
of the key proteins involved, 5-HT1A autoreceptors and 
SERT. Our data suggest that [5-HT] o in the DRN pri-
marily refl ect cytosolic 5-HT concentrations in neurites 
of serotonergic neurons, revealing some interesting 
properties of the serotonergic system when considered 
in light of structural organization of serotonergic 
nuclei. Thus, as 5-HT synthesizing enzymes, Tph2 and 
AADC, are present throughout the cytosol of serotoner-
gic neurons ( Joh et al., 1975 ), and Tph2, contrary to 
5-HT, is more abundant in cell bodies than in projec-
tion areas ( Weissmann et al., 1987 ), and while SERT is 
expressed abundantly along axons, but at a low level on 
the somatodendritic plasma membrane ( Tao-Cheng 
and Zhou, 1999 ), it can be hypothesized that newly syn-
thesized 5-HT “leaks out” of somatodendritic regions 
into the extracellular space from where it is then taken 
up into the axons, resulting in an inverted fl ow of trans-
mission of newly synthesized 5-HT compared with ca-
nonical synaptic transmission (see  Fig. 13 ). A further 
consequence of axonal expression of SERT is genera-
tion of a large 5-HT gradient across axonal plasma 
membrane, suggesting that [5-HT] o can also originate 
in axons, as the leakage is proportional to the trans-
membrane gradient. Additional research is required to 
characterize the relative contribution of axonal and 
dendritic nonexocytotic 5-HT release in supplying 
5-HT o in raphe nuclei. 
 Somewhat paradoxically, given the rapid forward 
transport of 5-HT–containing vesicles along axons, i.e., 
  50 μm min   1  in the axon of the giant cerebral neuron 
in Aplysia ( Goldberg et al., 1976 ), the nonvesicular 
nature of 5-HT release in the DRN implies that the 
VMAT2-containing vesicles in serotonergic axons 
in nonexcitable cells ( Erickson et al., 1992 ;  Scholze 
et al., 2000 ;  Sitte et al., 2000 ). Based on the pH depen-
dence, it appears that 5-HT crosses the plasma mem-
brane in its neutral form ( Erickson et al., 1992 ). The 
effl ux of 5-HT by passive diffusion from preloaded HEK 
293 cells was determined to occur with the fractional 
release of   1.2–1.5% min   1 , corresponding to the   of 
  64–78 min ( Scholze et al., 2000 ,  2001 ). Here, by using 
5-HT1A autoreceptor-activated GIRK channels as a 
5-HT o sensor, we estimated the lower limit of nonexocy-
totic 5-HT release rate in the DRN. Under conditions of 
inhibited VMAT2 and SERT, bath application of Trp 
produced an increase in GIRK conductance with the 
time constant of 82.3–89.0 s. Even faster kinetics were 
observed in recordings of fi ring rate and focal applica-
tion of Trp (  = 26.7 s), but because 5-HT reuptake was 
not inhibited in these experiments, the kinetics could 
have been accelerated also via a SERT-dependent 
mechanism. A considerably higher 5-HT effl ux rate ob-
served here, compared with that found in HEK 293 
cells, does not necessarily preclude diffusional effl ux in 
the DRN. It is likely attributable to structural character-
istics of serotonergic neurons, i.e., their long and thin 
dendrites and axons that substantially increase the 
plasma membrane surface over which 5-HT may dif-
fuse. In addition, the DRN is a region with the greatest 
density of SERT in the brain, and serotonergic cell bodies 
are surrounded by a dense network of SERT-immuno-
reactive neurites ( Qian et al., 1995 ). It is reasonable to 
assume that the high surface/volume ratio of thin 5-HT 
neuron neurites in combination with a high transmem-
brane gradient of 5-HT generated by SERT and 5-HT 
synthesis provide a basis for signifi cant passive 5-HT ef-
fl ux in the DRN. Thus, although transporter- and chan-
nel-mediated mechanisms cannot be fully ruled out, we 
suggest that continuous release of 5-HT in the DRN 
may be mediated by simple diffusion of 5-HT across the 
plasma membrane. 
 Given the substantial effl ux of cytosolic 5-HT in the 
presence of a large transmembrane 5-HT gradient, the 
passive effl ux of 5-HT could also occur from SERT-ex-
pressing axons in projection areas. Consistent with this 
hypothesis, SERT-independent 5-HT release was ob-
served in rat hippocampal slices after the application of 
5-HT–releasing amphetamine analogues as well as after 
the inhibition of VMAT2 ( Mlinar and Corradetti, 2003 ), 
whereas nonvesicular 5-HT release with an unidentifi ed 
mechanism was shown from synaptosomes obtained 
from mice in which the VMAT2 gene was deleted in se-
rotonergic neurons ( Narboux-Nême et al., 2011 ). Pas-
sive 5-HT effl ux possibly also occurs in axons of neurons 
that transiently express SERT during development, 
such as thalamocortical neurons ( Persico et al., 2001 ). 
Furthermore, a physiologically relevant passive effl ux of 
transmitter might not be limited to 5-HT. Similar to our 
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